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Globally, biodiversity is declining while emerging infectious diseases are on the rise. To 
explain this pattern, the “dilution effect” hypothesis predicts that with lower diversity, 
disease increases, because diversity “dilutes” disease.  Although there is strong support 
for this hypothesis, there is evidence to support the “amplification effect” hypothesis, 
which predicts lower disease with lower diversity. Recently, there has been a push to 
investigate underlying mechanisms than general patterns to create a more mechanistic 
framework across disease systems. However, mechanisms have been mostly examined 
with indirectly-transmitted disease systems (e.g., Lyme disease), while less attention has 
been directed towards directly-transmitted systems, such as rodent-hantavirus systems.  
 
For my dissertation, I investigated mechanisms behind diversity-disease patterns in 
directly-transmitted disease systems, using the North American deermouse (Peromyscus 
maniculatus)-Sin Nombre hantavirus (SNV) system as a model. SNV is an emerging 
zoonosis with high human fatality. A dilution effect has been primarily reported for this 
well-studied system, which exhibits density-dependent transmission. Because community 
composition than diversity pe se, is most likely responsible for a dilution effect, in this 
dissertation I primarily considered heterospecific competitors as the component of the 
community responsible for affecting disease. 
 
In Chapter 1, I briefly introduce my dissertation. In Chapter 2, I discuss theory and 
empirical evidence of mechanisms that underlie patterns between disease and diversity 
(or community composition) across rodent-hantavirus systems through a systematic 
literature review. I conclude that host density is most likely the primary mechanistic 
driver, with density-independent mechanisms (i.e. contact rates, probability of 
transmission given contact and infectious period) requiring further investigation. In 
Chapter 3, I experimentally validate the use of two enzyme immunoassays for measuring 
fecal corticosterone metabolites in deermice, as a measure of stress. In Chapter 4, I 
present observational data that voles and shrews have negative impacts on deermouse 
stress physiology but differentially influence scar numbers (a proxy for contact rates). In 
Chapter 5, I use a mathematical model with interspecific competition and a deconstructed 
transmission rate (i.e. contact rates and probability of transmission) to show that non-
monotonic patterns (increase then decrease) between competitor density and disease 
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CHAPTER 1 OVERVIEW OF DISSERTATION 
 
BACKGROUND 
Globally, biodiversity is declining while emerging infectious diseases are on the rise. To explain 
this pattern, the “dilution effect” hypothesis predicts that with lower diversity, there will be 
higher disease risk because diversity “dilutes” disease. However, community composition (e.g., 
competitors) may be more important than diversity per se. Although the “dilution effect” 
hypothesis has been tested across various disease systems, its underlying mechanisms have been 
studied mostly in vector-borne (e.g., Lyme disease) and environmentally-transmitted (e.g., 
amphibian trematodes) disease systems. However, mechanisms in directly-transmitted disease 
systems, such as rodent-hantavirus systems, have been relatively understudied. This is an 
important knowledge gap because mechanisms will differ between directly-transmitted and other 
disease systems. A mechanistic approach can help us better understand and predict how losses in 
biodiversity can impact disease outcomes in people, animals, and plants, across disease systems. 
RESEARCH OBJECTIVES 
Although rodent-hantavirus systems are commonly cited as examples of directly-transmitted 
disease systems that support the “dilution effect” hypothesis, we know little about the underlying 
mechanisms. The overall goal of this dissertation was to investigate the mechanisms that drive 
patterns between disease and diversity (or community composition) in directly-transmitted 
disease systems, using rodent-hantavirus systems as models. Through a systematic literature 
review, I collated the existing evidence on diversity-disease patterns across rodent-hantavirus 
systems, identified and synthesized mechanistic evidence, and demonstrated diversity-disease 
outcomes in a realistic modeling framework that incorporated opposing mechanisms. To 
empirically collect my own mechanistic evidence, I used Sin Nombre hantavirus (SNV), and its 
reservoir host, the North American deermouse (Peromyscus maniculatus, hereafter deermouse), 
2 
 
as a model system in western Montana grasslands. In this system, voles (Microtus spp.) are the 
dominant competitor of deermice with shrews (Sorex spp.) serving as an additional member in 
species-poor small mammal communities. Based on evidence from the literature, I hypothesized 
that voles would influence contact rates, induce chronic stress, and suppress immunity in 
deermice, with shrews having a lesser effect. To empirically quantify how competitors impacted 
stress physiology of deermice, I conducted experimental studies in the laboratory and field to 
validate two enzyme immunoassays for measuring fecal metabolites of corticosterone (the 
primary glucocorticoid hormone in deermice), as a measure of stress. Over approximately two 
years, I performed an observational study at Ninepipe WMA where I trapped small mammals 
monthly and collected measures of contact rates (scar numbers), immunity, and stress physiology 
from deermice (using one of the immunoassays from Chapter 3 in addition to other measures). 
Motivated by the theoretical results of Chapter 2 and empirical results of Chapter 4, I modified 
an existing mathematical model of the deermouse-SNV model to run simulations where I 
incorporated effects of vole competitors on deermouse density, intraspecific contact rates, and 
immunity via stress physiology, to examine single and interactive effects on disease outcomes.   
RESULTS 
In Chapter 2, I described all the possible density-dependent and -independent (contact rates, 
probability of transmission given contact, infectious period) mechanistic links between disease 
prevalence and species diversity (or community composition) for directly-transmitted diseases 
with one primary reservoir and density-dependent transmission, a combination representative of 
rodent-hantavirus systems. Through a systematic review, I found evidence for dilution, 
amplification, and neutral outcomes across rodent-hantavirus systems. Most importantly, 
mechanistic studies primarily examined host density, with fewer investigating density-
independent mechanisms. A modeling exercise inspired by empirical data, with the deermouse-
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SNV system, demonstrated a non-monotonic outcome between diversity and disease when 
density-dependent and -independent mechanisms competed within the same system. In Chapter 
3, I provided experimental evidence that physiologically validated two different enzyme 
immunoassays for quantifying fecal corticosterone metabolites (FCMs), a measure of stress in 
deermice and showed that confinement in a live-trap for more than four hours can increase 
FCMs in free-ranging deermice. In Chapter 4, I demonstrated associations between 
heterospecific competitors (voles and shrews) and measures of contact rates (scar numbers) and 
stress physiology (FCMs, body condition). In particular, only shrews decreased stress response 
FCMs in deermice whereas both shrews and voles decreased body condition scores. I also found 
that deermice had higher neutrophil/lymphocyte ratios (a measure of stress) during 
spring/summer, and lower white blood cell counts (a measure of immunity), with higher scar 
numbers (a measure of contact rates) in summer. In Chapter 5, I demonstrated that a non-
monotonic outcome between competitor density and disease prevalence, a result of competing 
density-dependent and -independent mechanisms, occupied most of the parameter space 
examined, which was kept realistic for the deermouse-SNV system.  
CONCLUSIONS 
The systematic review suggests that host density is most likely the primary mechanism by which 
diversity can indirectly impact disease prevalence, and that density-independent mechanisms 
(contact rates, probability of transmission given contact, and infectious period) still require 
further empirical investigation. The latter is especially important because non-monotonic 
outcomes between diversity and disease could occur when density-independent mechanisms 
compete with host density in the same disease system. Given the results from the observational 
study at Ninepipe WMA, stress physiology could perhaps be an important mediator by which 
diversity (or community composition) may impact probability of transmission given contact, 
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thereby increasing the host’s susceptibility to infection or infectiousness. Lastly, non-monotonic 
outcomes stemming from competing mechanisms, occupied most of the parameter space 
examined for the deermouse-SNV system. This is crucial because non-monotonic outcomes 
could be misinterpreted since researchers typically look only for linear relationships in field 
studies. Indeed, such misinterpretations could help explain why some studies report no 



































CHAPTER 2 MECHANISTIC LINKS BETWEEN BIODIVERSITY AND DIRECTLY-
TRANSMITTED DISEASES: A REVIEW OF THEORY AND EMPIRICAL EVIDENCE 
FROM RODENT-HANTAVIRUS SYSTEMS 
 
ABSTRACT 
Globally, biodiversity is declining while emerging infectious diseases are on the rise. To explain 
this pattern, the “dilution effect” hypothesis predicts that with lower diversity, there will be 
higher disease risk because diversity “dilutes” disease. The mechanisms behind this hypothesis 
have been relatively understudied in directly- transmitted disease systems, such as 
orthohantaviruses (hereafter hantaviruses) and their rodent reservoirs. Here, we aim to: (1) 
characterize mechanisms underlying diversity-disease relationships in rodent-hantavirus systems, 
(2) review the literature to identify and synthesize mechanistic evidence, and (3) demonstrate 
relationships that could occur from competing mechanisms within a modeling framework. Our 
findings suggest that host density is the primary mechanistic driver of a diversity-disease pattern, 
and density-independent mechanisms (intraspecific contact rates, probability of transmission, 
and infectious period) still require further investigation. Our modeling exercises demonstrate that 
a decrease (dilution) or increase (amplification) in disease prevalence could occur, as well as a 
non-monotonic pattern (increase then decrease), depending on mechanisms considered (density-
dependent and -independent) and their relationship with diversity. The modeling findings 
advocate for the examination of understudied mechanisms and could explain the idiosyncratic 
nature of diversity-disease relationships. Although this review focuses on directly-transmitted 
diseases, our mechanistic approach and findings can be extended to other diseases.  
 
THE RELATIONSHIP BETWEEN DIVERSITY AND DISEASE 
Globally, anthropogenic actions have led to a rapid loss in species diversity [1] while 
emerging infectious diseases of humans [2] and wildlife [3] have been on the rise. To explain 
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this alarming pattern, the “dilution effect” hypothesis postulates that as species diversity 
decreases, disease risk increases (e.g. higher disease prevalence or transmission), because 
diversity “dilutes” disease [4]. This hypothesis has attracted a great deal of attention because if 
true and universal, conserving biodiversity would be a win-win scenario for both conservation 
and public health. However, there has been a heated debate about its generality and applicability 
across host-parasite systems [5-8]. This is partially because of evidence that supports an 
alternative hypothesis, the “amplification effect” hypothesis, which predicts that as diversity 
decreases, disease risk decreases [4,9]. The debate resulted in a call to move beyond simply 
describing correlations between diversity and disease, to investigating and identifying the 
mechanisms behind these patterns [10-12]. Such an approach can generate mechanistic models 
that can guide useful strategies for mitigation and prevention of infectious diseases [13].  
Of the empirical studies focused on testing mechanisms that lead to disease dilution or 
amplification [4], most have been with vector-borne parasites, such as Borrelia burgdorferi 
(causative agent of Lyme disease) (e.g. [14]), and parasites with complex life cycles, such as 
amphibian trematodes (e.g. [15]). Although most infectious diseases are transmitted directly, 
relatively few studies have examined the mechanisms that underlie relationships between such 
diseases and biodiversity [11,13]. This is problematic because mechanisms can differ between 
directly-transmitted and other systems. Therefore, more empirical studies that investigate 
mechanisms in directly-transmitted disease systems are urgently needed. 
 
DIVERSITY-DISEASE PATTERNS IN DIRECTLY-TRANSMITTED DISEASE SYSTEMS 
Orthohantaviruses (Orthohantavirus; Hantaviridae; Bunyavirales; hereafter hantaviruses), 
and their rodent hosts, [16] are examples of directly-transmitted disease systems, which have 
received considerable attention from a diversity-disease perspective. Indeed, these systems are 
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commonly cited as examples of directly-transmitted diseases that support the “dilution effect” 
hypothesis. The focus on these systems is likely because of two reasons. Firstly, because several 
hantaviruses can cause fatal disease in humans, there is an urgency to investigate their 
epidemiology and ecology to help inform public health [17]. Secondly, these systems meet the 
criteria necessary for diversity to “dilute” disease because other species do not typically serve as 
viable hosts and hantavirus reservoirs are likely to persist as species diversity declines [18]. 
To various degrees, six recent reviews have synthesized evidence about diversity-disease 
relationships across rodent-hantavirus systems [17,19-23]. However, there has been no 
systematic review delving into the mechanisms that drive these relationships, the focus of this 
review. Here, we summarize what is presently known about diversity-disease patterns. Next, we 
summarize and synthesize empirical evidence about the underlying mechanisms. Lastly, we 
demonstrate the significance of considering simultaneous mechanisms within the modeling 
framework of a directly-transmitted disease system.  
Although we focus on rodent-hantavirus systems, our mechanistic approach of reviewing 
theory and evidence can be valuable across host-parasite systems. Importantly, our quantitative 
approach of incorporating multiple mechanisms within a modeling framework can be customized 
and extended to other systems. 
DIVERSITY-DISEASE PATTERNS IN RODENT-HANTAVIRUS SYSTEMS 
 
HANTAVIRUSES AND THEIR RESERVOIR HOSTS 
Hantaviruses are found in Eurasia, Africa, and the Americas [24]. Several hantaviruses 
have been classified as emerging zoonoses, including Sin Nombre virus (SNV) and Andes virus 
(ANDV) in the Americas, Puumula virus (PUUV) in Europe, and Hantaan virus (HTNV) in Asia 
[25]. SNV and ANDV cause hantavirus cardiopulmonary syndrome with up to a 40% fatality 
rate in humans. In contrast, HTNV and PUUV cause hemorrhagic fever with renal syndrome 
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with lower fatality rates [17,26]. Humans are typically exposed to hantaviruses indirectly via 
aerosolized excreta and secreta of infected rodents [17]. 
Hantaviruses are primarily transmitted between hosts during aggressive encounters 
[17,27], although indirect transmission may also occur [28-29]. Hantaviruses typically cause a 
chronic infection in their hosts despite life-long production of antibodies [17]. Although 
infection does not typically lead to overt clinical signs [30], some studies with free-ranging hosts 
have found negative effects, such as lower survival [31] and reduced fecundity [32].  
 
EVIDENCE FOR DIVERSITY-DISEASE RELATIONSHIPS IN RODENT-HANTAVIRUS 
SYSTEMS 
Our literature review identified 35 studies (Table 2.1), including studies that did not test 
for mechanisms (see supplementary information about search process). However, two were 
meta-analyses [63-64] that included studies our search had already found. Consequently, these 
were not included in Table 2.1, but we discuss them further in the supplementary information. 
Out of the remaining 33 studies, three were experimental [39,54,59].  We also note that a few 
studies used subsets of the same datasets (N = 8, Table 2.1), which we counted only once if they 
generated identical outcomes. In the end, most studies identified a dilution effect (N = 12 
[18,33,36-38,41,43,46,48,54,58,60]). Others found either no effect (N = 6 [49,51,53,55,57,59]), 
amplification (N = 2 [42,50]), or a non-monotonic outcome (N = 1, [62]). The remaining studies 
reported conditional outcomes: a “component amplification” effect with overall dilution or no 
effect depending on geographic location (N = 1, [11]), amplification or a non-monotonic 
relationship depending on the diversity metric (N = 1, [61]), and dilution or no effect depending 
on the diversity (N = 1, [35]) or disease (N = 2, [47,50]) metric. 
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Most studies were done on a small spatial scale (i.e. field plots), which is the scale where 
we expect diversity to affect disease spread. Two studies were performed at a larger spatial scale 
(i.e. municipality or district) [61-62], which we revisit in the modeling section. 
 
DIVERSITY-DISEASE MECHANISMS: THEORY AND EVIDENCE 
Rodent-hantavirus studies have used various metrics to quantify disease, including prevalence of 
hantavirus antibody (i.e., seroprevalence), number of infected individuals, and individual 
probability of infection (i.e., force of infection). Because most studies used antibody prevalence, 
we focused on this metric. 
 
DETERMINANTS OF DISEASE PREVALENCE  
For directly-transmitted diseases with one primary reservoir host, such as hantaviruses, 
there are three determinants of R0, which dictates disease prevalence at equilibrium [4]. 
Therefore, when antibody prevalence is the metric used, there are three mechanisms that can 
directly drive diversity-disease relationships (Figure 2.1, gray arrows). The first is contact rates 
between infected and susceptible hosts, which diversity can affect directly (sensu encounter 
reduction, [4], Figure 2.1, gray arrow) or indirectly via host density (sensu susceptible host 
regulation, [4], Figure 2.1, blue arrow). The second is probability of transmission given contact 
(sensu transmission reduction, [4], Figure 2.1, gray arrow), representing host infectiousness and 
susceptibility to infection [65], which can also be affected indirectly via density (sensu 
susceptible host regulation, [4], Figure 2.1, blue arrow). The third is the infectious period of 
hosts (sensu infected host mortality, recovery augmentation, or both [4], Figure 2.1, gray arrow), 
which can be affected indirectly via density as well (sensu susceptible host regulation, [4], Figure 
2.1, blue arrow). For rodent-hantavirus systems, the infectious period is determined by host 
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survival because hosts never recover from infection. If diversity affects any of these 
mechanisms, it can alter disease prevalence and lead to dilution or amplification. 
As mentioned above, host density can play a powerful role in how the three determinants 
of R0 can influence disease prevalence. However, we do not consider host density as a direct 
determinant of R0 because it can only affect disease indirectly. Importantly, the indirect effect of 
density on disease via intraspecific contact rates, will only apply when disease transmission is 
density-dependent. With density-dependent transmission, contact rates are expected to increase 
directly with host density (Figure 2.1, blue arrow)— that is, the true contact rate will be 
determined by , where κ is a constant and N is host density [66]. For example, an increase in 
diversity could affect density-dependent contact rates by reducing host density and leading to 
lower overlap of home ranges, thereby reducing contact rates. For diversity to directly affect 
contact rates, it needs to do so independent of host density (Figure 2.1, gray arrow). For example, 
an increase in diversity could affect density-independent contact rates by changing host behavior, 
such as restricting movement in the presence of competitors. However, with frequency-
dependent transmission, contact rates are independent of density [66]; therefore, diversity cannot 
indirectly impact contact rates via density.  
In contrast to contact rates, mode of transmission does not matter when host density 
affects the other two determinants of R0 — probability of transmission given contact and 
infectious period (Figure 2.1, blue lines). Empirical evidence suggests that a higher host density, 
could increase the probability of transmission given contact (hereafter, probability of 
transmission), via stress-induced suppression of immunity (e.g. [67-68]). Alternatively, higher 
host density could reduce probability of transmission if it leads to enhanced immunity (e.g. [69]). 
Furthermore, evidence suggests that higher density could increase the infectious period by 
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increasing host survival if access to food resources is increased (e.g. [70]). However, higher 
density could also decrease the infectious period if it leads to a decline in food availability (e.g. 
[71]). Therefore, whenever we examine relationships between diversity and disease, there is 
evidence to suggest the need to consider the effects of density, not only on contact rates but also 
on the probability of transmission and infectious period.  
In the end, it is important to consider that multiple mechanisms, acting independent 
(Figure 2.1, gray lines) or dependent on host density (Figure 2.1, blue lines), may be at play at 
any given time, which may lead to opposing, additive, or synergistic effects on outcomes.  
We found 14 studies that examined mechanisms behind diversity-disease relationships 
for rodent-hantavirus systems. Studies have paid most attention to host density, and to a lesser 
extent, contact rates independent of density as hypothetical mechanisms, whereas probability of 
transmission, and infectious period, have been neglected (Table 2.1). Below, we review existing 
evidence to provide a strong foundation for future studies. We focus on the deermouse-SNV 
system because it was the most commonly investigated (Table 2.1). However, we provide some 
evidence for the bank vole-PUUV system in the supplementary information. 
 
HOST DENSITY 
Host density can have a central role in driving disease prevalence by potentially affecting 
each of three mechanisms: contact rates, probability of transmission, and infectious period. 
Consequently, when diversity is negatively or positively associated with host density, there will 
be fewer or more hosts, respectively, with higher diversity, which can indirectly influence 
contact rates, probability of transmission, and infectious period (Figure 2.1).  
For host density to indirectly drive diversity-disease relationships, two conditions must be 
met: (1) host density must associate with species diversity, and (2) transmission must be density-
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dependent for contact rates to serve as a mechanism (Figure 2.1, blue line). However, even if 
transmission is density-dependent, density-mediated changes in contact rates are not the only 
possible mechanism; probability of transmission and infectious period could also serve as 
possible mechanisms (Figure 2.1, blue lines). Generally, when diversity negatively affects 
density, dilution would be expected. Alternatively, if diversity positively affects density, 
amplification would be predicted. Below, we examine evidence for the two conditions listed 
above.  
There is compelling evidence that host density is a key mechanism driving the 
relationship between diversity and disease. This is exemplified by four empirical studies that 
identified dilution, and also a negative relationship between diversity and deermouse density 
(Table 2.1, [11, 33, 36-37]). However, depending on the ecological scenario, diversity does not 
always lead to a decrease in host density, and subsequently dilution is not observed. For 
example, Luis et al. [11] found a dilution effect in the southwest U.S.A., where they also saw a 
negative relationship between small mammal diversity and deer mouse density; however, they 
found no evidence for dilution in Montana, U.S.A., where there was no relationship between 
diversity and density (Table 2.1). Although the meta-analysis by Vadell et al. [63] merged 
deermouse-SNV with other systems, they found that host density was the main predictor of 
hantavirus prevalence, and once accounted for, there was no significant effect of diversity on 
disease prevalence, and only weak evidence for a negative relationship between diversity and 
density. Taken together, these studies strongly suggest that density is a strong indirect 
determinant of disease, and when diversity decreases host density, there is a dilution effect, but 
when diversity does not decrease host density, there is no effect.  
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A positive relationship between host density and disease prevalence is expected if there is 
density-dependent transmission. In the deermouse-SNV system, researchers have not 
consistently found a simultaneous positive relationship between host density and disease 
prevalence ([33, 36-37] but see [40]), and some have concluded that diversity could not affect 
contact rates via density. However, Luis et al. [72] showed that deermouse density does indeed 
correlate positively with SNV prevalence, but with a variable time lag, which is most apparent 
when using a dynamical mathematical model with density-dependent transmission. Because 
SNV prevalence lags behind deermouse density, testing for a simultaneous relationship between 
current deermouse density and SNV prevalence can lead to misinterpretations.  Given the rising 
support for density-dependent transmission, host density may indeed serve as a key indirect 
determinant of disease prevalence. 
However, there are two studies that contradict this line of reasoning. The first is by 
Dizney & Dearing [38], from Utah U.S.A., who found a dilution effect at two sites varying in 
diversity but not current deermouse density. However, because of inherent time lags in how SNV 
prevalence manifests, it is unclear if the two sites were indeed similar. The second study is by 
Carver et al. [41], from one site in Montana, U.S.A, who found a positive relationship between 
vole and deermouse densities. Although the authors found no relationship between SNV 
prevalence and vole density (i.e. no effect), they did find a dilution effect when voles were 
present (i.e. a temporal dilution).  
Despite their contradictory findings, these two studies used sites included in the more 
extensive studies by Clay et al. [33] and Luis et al. [11]. Although Clay et al. [33] did find 
dilution, they also found a negative relationship between diversity and density by using data 
collected over a longer time span from 16 sites. In contrast to Carver et al. [41], Luis et al. [11] 
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detected no dilution and no relationship between density and diversity when they analyzed five 
more sites from Montana. However, Luis et al. [11] used density and diversity values that were 
averaged across time, whereas Carver et al. [41] examined average values from month-to-month. 
Therefore, it will be important to further examine how incorporating temporal fluctuations in 
diversity, density and disease metrics could affect study conclusions. In summary, differences in 
study design and data analysis could be why these two studies do not fit the overall pattern. 
 
DENSITY-INDEPENDENT CONTACT RATES 
For directly-transmitted diseases with density-dependent transmission, intraspecific 
contact rates could be affected by species diversity in two ways— indirectly, through changes in 
host density (Figure 2.1, blue arrow), and directly, independent of density (Figure 2.1, gray 
arrow). To determine if diversity affects density-independent contact rates, studies must ensure 
that contact rates are not changing due to density (Figure 2.1, blue arrow). When diversity 
directly reduces contact rates (e.g. via changes in host behavior), dilution can emerge, whereas 
amplification can occur, when diversity directly increases contact rates (Figure 2.1, gray arrow).  
Only five studies tested contact rates as a hypothetical mechanism. Four directly 
evaluated contact rates through observational or experimental design setups, whereas one did so 
indirectly, as a component of the transmission rate (Table 2.1).  
Two of the five studies were performed at sites naturally varying in deermouse density. 
Therefore, density was not manipulated but accounted for during analyses. The first study is 
from Utah, U.S.A., which found lower intraspecific contact rates at more diverse sites [34]. The 
authors used foraging arenas and infrared cameras to document the frequency and duration of 
contacts. Their findings suggested that a higher diversity decreases frequency of contacts but not 
their duration. Although interesting, two limitations were the inclusion of an influential outlier, 
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and the foraging arenas may have artificially modified behavior. The second study from 
Montana, U.S.A., found that the number of scars (a proxy for contact rates) was differentially 
associated with densities of shrews (Sorex spp.) and voles (Microtus spp.), but not deermice [42]. 
Despite intriguing conclusions, number of scars is unlikely to be a very precise measure. Taken 
together, although these studies provide motivating evidence, it is challenging to definitively 
make conclusions about the role of density-independent contact rates because density was not 
controlled experimentally. 
Two other studies controlled for the effects of density more reliably. One of these two 
studies was done in Utah, U.S.A., where their two sites naturally varied in rodent diversity, but 
not current deermouse density [38]. Although there was no site replication, deermice at the less 
diverse site exhibited behaviors that could potentially increase contact rates (e.g. time spent 
foraging). However, because they used foraging arenas, it is unclear if behaviors were contrived, 
and whether they would lead to higher contact rates. The second study by Rubio et al. [39] used 
experimental enclosures in Mexico and found that rodent diversity did not influence deermouse 
contact rates. Although this study did not test deermice for SNV, used foraging arenas to record 
behaviors, and included treatments with only one or two nonhost species, they ensured that host 
density was held constant, making it more likely they measured density-independent contacts.  
The last study by Luis et al. [11] found that for a given host density, the SNV 
transmission rate (product of contact rates and probability of transmission), increased with higher 
small mammal diversity in Montana, and Southwest U.S.A. The authors called this pattern a 
“component amplification” because the net effect was either dilution or no effect. However, they 
could not disentangle contact rates from probability of transmission. 
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Although the aforementioned studies have strengths and weaknesses, they provide 
intriguing, yet inconclusive evidence, about whether diversity can affect contact rates 
independent of density. Nevertheless, Rubio et al. [39] may have most reliably examined 
density-independent contact rates by experimentally controlling for density in replicated 
treatment groups. However, community composition was different between their study in 
Mexico and studies in U.S.A., which makes definitive conclusions more difficult. 
 
DENSITY-INDEPENDENT PROBABILITY OF TRANSMISSION GIVEN CONTACT  
The probability of transmission will depend on host susceptibility to infection, and 
infectiousness, both of which are regulated by host immunity. However, studies that aim to test 
probability of transmission independent of density, must ensure that they account for changes via 
density (Figure 2.1, blue arrow) regardless of transmission mode. When diversity directly 
decreases or increases the probability of transmission, dilution or amplification can emerge, 
respectively (Figure 2.1, gray arrow). 
There are two studies that investigated probability of transmission as a hypothetical 
mechanism (Table 2.1). Because intricate physiological processes (e.g. endocrine) will typically 
affect host susceptibility or infectiousness, this mechanism can be difficult to estimate from field 
data [73]. Such complexity may explain why this mechanism has been rarely studied.  
The first study by Luis et al. [11], mentioned previously, could not identify whether 
contact rates, probability of transmission, or both, were responsible for a “component 
amplification”. The second study by Eleftheriou et al. [42], also mentioned previously, reported 
that densities of shrews and voles, but not deermice, were associated with measures of stress 
physiology in deermice. Although their findings come with limitations, they are relevant because 
changes in stress could negatively impact immunity, thereby increasing host susceptibility or 
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infectiousness. Therefore, there is some evidence to suggest that probability of transmission, 
independent of density, could potentially play an influential role. Indeed, both aforementioned 
studies suggest that diversity (or community composition) may have a positive impact on 
probability of transmission, an effect potentially mediated via stress physiology.  
 
DENSITY-INDEPENDENT INFECTIOUS PERIOD  
Because hosts never recover from hantavirus infection, host survival determines the infectious 
period. Therefore, when diversity directly reduces the survival of infected hosts, by either 
increasing natural and/or disease-induced mortality, it can reduce their infectious period and 
cause dilution. Alternatively, diversity could increase host survival and lead to amplification 
(Figure 2.1, gray arrow). In either case, density-independent infectious period could serve as a 
hypothetical mechanism. However, if diversity also regulates host density, it could become 
difficult to unravel the indirect effects of density (Figure 2.1, blue arrow).  
Only one study has examined density-independent infectious period as a potential mechanism. 
This study used deermouse persistence as a measure of infectious period, which makes 
separating survival from dispersal challenging [33]. Although deermouse persistence was lower 
with higher rodent diversity, this conclusion did not account for density effects (Figure 2.1, blue 
arrow). Thus, even if we assumed that dispersal was minimal, it would be misleading to state that 
dilution was due to a reduction in infectious period independent of density. 
 
EFFECTS OF MULTIPLE MECHANISMS ON DISEASE OUTCOMES  
CONCURRENT DILUTION AND AMPLIFICATION EFFECTS 
Although researchers typically search for dilution or amplification, Luis et al. [11] demonstrated 
that both can occur at the same time via different mechanisms in the deermouse-SNV system. 
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Therefore, researchers should consider whether concurrent effects could exist in their own 
systems as they examine all relevant mechanisms at play. To motivate this idea, we investigate 
through simulations how interactive mechanisms could modify outcomes using the deermouse-
SNV system as a model.  
 
SIMULATION EXERCISES WITH THE DEERMOUSE-SNV SYSTEM 
Here, we use a simpler version of the Susceptible-Infected (SI) model from [11], which 
assumes density dependence (supplementary information). There is no recovered class because 
deermice never recover. We first generated linear relationships between host density and species 
diversity, and between transmission rate (the product of density-independent contact rates and 
probability of transmission) and species diversity (supplementary information, Figure S2.1). 
These relationships were inspired by empirical patterns [11].  
By incorporating different relationships between each mechanism and diversity, we 
completed three scenarios to visualize patterns that could manifest at equilibrium (supplementary 
material, Table S2.1). Firstly, diversity influenced only host density (scenario 1, Figure 2.2). 
Secondly, diversity affected only the transmission rate for a given density (scenario 2, Figure 
2.2). Thirdly, diversity impacted both density and transmission rate (scenario 3, Figure 2.2).  
In scenario 1, where diversity negatively affected density, dilution occurred (Figure 2.2, 
blue line). In scenario 2, where diversity positively affected the transmission rate, amplification 
occurred instead (Figure 2.2, red line). In scenario 3, where diversity negatively affected density, 
but positively influenced transmission rate, our findings showed a non-monotonic relationship, 
where prevalence peaked at intermediate levels of diversity (Figure 2.2, black line). Collectively, 
we show that dilution, amplification, or a non-monotonic relationship, could theoretically 
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develop within the same system. These results were robust to the disease metric used 
(supplementary material, Figure S2.2). 
A non-monotonic relationship has previously been described as a potential pattern across 
systems, but under a different framework dependent on scales of biodiversity [13,74-75]. 
Specifically, at lower diversity, there could be no host species, so disease risk would be zero 
(e.g., urban centers). However, as diversity increases (e.g., urban to rural gradient), host species 
would be more likely to occur, thereby increasing disease risk. Conversely, at higher diversity, 
non-competent species would also be likely to exist (e.g., forests), thereby “diluting” disease. 
Such non-monotonic patterns have been described by studies we found during our search [61-
62]. These two studies, done at broad spatial scales, found non-monotonic patterns between 
predator diversity and cases of human infections. 
However, here, we show that a non-monotonic relationship between diversity and 
disease, can also occur independent of scale, when diversity affects determinants of prevalence 
in opposing directions. This pattern occurs because the dominant mechanism changes across 
values of diversity. At lower diversity, the transmission rate is the primary mechanism that 
increases disease whereas at higher diversity, host density predominates to decrease disease 
because density becomes too low to sustain transmission, despite a maximum transmission rate. 
Results from more complex models with the same system, where the transmission rate was 
deconstructed into its two components, demonstrated similar patterns (Eleftheriou & Luis, 
Chapter 5). Those findings suggest that non-monotonic outcomes could be misinterpreted as no 
effect, potentially helping to explain why some studies may report no pattern (Table 2.1).  
Given that we used a simple mathematical model with density-dependent transmission, 
our modeling approach can be applied to other systems, as long as additional mathematical 
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equations are incorporated that address system specifics. Using this approach, researchers can 
determine how mechanisms that vary in their relationship to diversity could alter final outcomes. 
This approach can also inform prospective studies, to help guide what mechanisms will be the 
most critical to evaluate empirically.  
  
CONCLUSIONS AND FUTURE DIRECTIONS  
In the context of the “dilution effect” hypothesis, we conclude that host density is the 
primary mechanism that has received the most attention from empirical studies using rodent-
hantavirus systems as models of directly-transmitted diseases. Indeed, several studies have 
provided support for host density as the strongest determinant of hantavirus prevalence, whereby 
dilution, amplification, or neutral outcomes can culminate according to the relationship between 
density and diversity. If there is a negative relationship between diversity and density, we would 
expect to see dilution as exemplified by several studies (Table 2.1). Alternatively, if there is a 
positive relationship, we would expect amplification, as shown by one study from Argentina 
(Table 2.1). However, if there is no relationship, we would expect no effect, a prediction 
supported by two studies (Table 2.1). Further support comes from studies that did not report a 
disease outcome but found a negative relationship between density and diversity (Table 2.1). 
Similarly, a meta-analysis by Rubio et al. [76] found lower small mammal diversity but higher 
host density in fragmented habitats. We acknowledge that the small number of studies highlights 
the need for further investigation to verify and generalize these conclusions. 
Despite our claim that host density appears to be the primary mechanistic driver, we 
know little about which mechanisms are actually affected (Figure 2.1, blue lines). Broadly, we 
also know much less about the roles of density-independent mechanisms: contact rates, 
probability of transmission, and infectious period. The latter becomes significant when we 
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consider studies that find dilution or amplification in the absence of the expected relationship 
between diversity and density. For example, Khalil et al. [46] found a positive relationship 
between nonhost and host densities despite finding a dilution effect (Table 2.1), suggesting that 
density-independent mechanisms may be at play. Therefore, we require more empirical studies to 
further characterize understudied mechanisms. 
When testing for relationships between diversity and disease, it will be crucial to consider 
the likelihood of competing dilution and amplification within the same system. Our simulation 
exercises emphasize that contrasting outcomes can result, depending on the relationship between 
each mechanism and diversity. These outcomes further highlight the need to expand our 
knowledge about understudied mechanisms because they could compete with density to affect 
the net outcome. Consequently, to best inform disease control and biological conservation, we 
suggest that researchers use similar exercises with other systems to elucidate theoretical 
outcomes that could potentially manifest in nature from competing mechanisms.  
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Figure 2. 1 Conceptual diagram describing possible relationships between diversity and 
prevalence for a directly-transmitted disease with density-dependent (DD) transmission and one 
primary reservoir host. Arrows propose hypothetical effects that diversity may have on 
mechanisms that determine disease prevalence. Diversity can indirectly determine prevalence via 
DD mechanisms (blue arrows), or directly (gray arrows) via density-independent mechanisms 
(contact rates, probability of transmission given contact, and infectious period). Numbers in 
brackets illustrate number of studies across rodent-hantavirus systems that found support for 






Figure 2. 2 Simulation outcomes for three scenarios where density-dependent and density-
independent mechanisms varied in their relationship with diversity, using a mathematical model 
of the deermouse-Sin Nombre virus system. Scenario 1 (blue): When diversity has a negative 
effect on host density, a dilution effect emerges. Scenario 2 (red): When diversity has a positive 
effect on transmission rate for a given density, an amplification effect results. Scenario 3 (black): 













Table 2. 1 Diversity-disease studies with rodent-hantavirus systems. We list data on the disease system, diversity-disease outcome, 
empirical support (with directionality) for density-dependent and -independent mechanisms (contact rates, probability of transmission, 
and host survival), metrics of diversity and disease, and study reference.  
 
Host-virus system Outcome Host 
density 











P. maniculatus–SNV Da - . . -? RDY AP [33]  
 Da - -? . . RDY AP [34] 
 N . . . . SDY AP [35] 
 D . . . . PDY AP [35] 
 D - . . . SDY AP [36] 
 D - . . . SDY AP/NI [37] 
 D NA - . . RDY AP [38] 
 . NA N . . RDY . [39] 
 Db - NA NA . SDY AP/NI [11] 
 Nc N . . . SDY AP/NI [11] 
 CAb,c NA +? +? . SDY AP [11] 
 Db . . . . RDY AP [40] 
 TDc + . . . NHP AP [41] 
 Db . . . . SDY AP [18] 
 . . + or NM + . NHD . [42] 
O. palustris – BAYV D . . . . SDY AP [43] 
M. glareolus – PUUV A . . . . SDY AP [44] 
 Dd . . . . SDY AP/NI [45] 
 Dd + . . . NHD IP [46] 
 . d - . . . NHD . [46] 
 D . . . . NHPr AP [47] 
 N . . . . NHPr NI [47] 
 D . . . . NHD IP [48] 
 N . . . . NHPr AP/NI [49] 
O. longicaudatus – ANDV D . . . . RDY NI [50] 
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Host-virus system Outcome Host 
density 











 N . . . . RDY AP [50] 
 N N . . . SDY AP/NI [51] 
 A + . . . RDY NI [52] 
R. rattus – THAIV N . . . . SDY IP [53] 
Various D - . . . RDY AP [54] 
 N . . . . RDY AAP [55] 
 . - . . . SDY . [56] 
 N . . . . SDY AP [57] 
 D . . . . RDY NI [58] 
 N . . . . RDY AP [59] 
 D . . . . SDY DP/HI [60] 
 A . . . . NPDY HI [61] 
 NM . . . . DPDY HI [61] 
 NM . . . . PDY HI [62] 
CATEGORIES: Prob. of transmission = probability of transmission given contact, Ref. = reference, HOST-VIRUS SYSTEM: SNV 
= Sin Nombre virus, BAYV = Bayou virus, PUUV = Puumula virus, ANDV = Andes virus, THAIV = Thailand virus OUTCOME: D 
= dilution, A = amplification, CA = component amplification (i.e. not the main effect), TD = temporal dilution. DISEASE METRIC: 
AP = antibody prevalence, NI = number of infected hosts, IP = infection probability, AAP = antibody and/or antigen prevalence, DP = 
disease present (i.e. presence of infected rodents), HI = human infection cases, DIVERSITY METRIC: RDY= rodent diversity, SDY 
= small mammal diversity, PDY = predator diversity, NHP= nonhost presence, NHD = nonhost density, NHPr = nonhost proportion, 
NPDY = nocturnal predator diversity, DPDY = diurnal predator diversity. ALL:  ‘.’ = not explicitly examined, ‘+’ = positive 
relationship, ‘-’ = negative relationship, N = no relationship, NM = non-monotonic relationship, NA= not applicable (variable 






LITERATURE REVIEW METHODS  
We searched the literature for studies across rodent-hantavirus systems with the Google Scholar 
search engine using the following key words: “dilution effect” OR “amplification effect”, 
“hantavirus”, “disease”, “infection”, and “species diversity”. We restricted our literature search 
to peer-reviewed field studies (observational or experimental), and published in English, until 
March 28th, 2021. We also searched through reference lists of the six reviews mentioned in the 
main text, to identify studies our original search may have missed. We aimed to include only 
empirical studies that examined relationships between disease and diversity (or community 
composition) across rodent-hantavirus systems, with or without mechanistic evidence. 
This search approach generated 344 results when “dilution effect” was included and 87 
results when “amplification effect” was included. We selected relevant articles for further 
examination by reading through every article’s title. The abstract was reviewed only when there 
was not enough information to decide from the title alone. Articles with titles and abstracts 
deemed relevant were reviewed further to evaluate if they should be included, as stated above.  
 
EVIDENCE FROM META-ANALYSES 
During our literature search, we found two meta-analyses that focused on studies primarily not 
testing for a diversity-disease relationship. The first is by Vadell et al. [1], with disease systems 
from 22 studies in the Americas, and the second by Milholland et al. [2], with disease systems 
from 67 studies in Asia, Europe and the Americas. The first meta-analysis investigated the effect 
of rodent diversity on hantavirus prevalence and found no patterns after accounting for host 
density. The second meta-analysis examined the effect of small mammal richness and phylogeny 
on hantavirus prevalence and found that both were negatively associated with prevalence. 
However, host density was not included in their models. In summary, these two studies came to 
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contrasting conclusions, most likely because they used different studies (shared only six) and 
analytical approaches (e.g. accounting for density). 
 
HOST DENSITY: BANK VOLE-PUUV SYSTEM 
Several studies have found evidence that supports density-dependent transmission in the 
bank vole-PUUV system [3-5] suggesting that indirect effects via host density could result in a 
dilution effect. Density-dependent transmission has been echoed by Voutilainen et al. [6] and 
Khalil et al. [7], who found that bank vole density was important in predicting the probability of 
PUUV infection. However, not all studies found such a relationship. For example, although 
Tersago et al. [8] identified a critical threshold density required for PUUV persistence in vole 
populations, they did not find a relationship between vole density and PUUV prevalence during 
their two-year study. Similarly, Thoma Palo et al. [9] found no density-disease relationship over 
a three-year period. However, given that time lags may play a significant role in rodent-
hantavirus dynamics (e.g., [10]), a shorter temporal window of data collection could make 
density-dependent transmission more challenging to detect.   
Although most mechanistic studies that used the bank vole-PUUV system did not always 
examine relationships between host density and diversity per se, studies did look at relationships 
between host and nonhost densities (or their proportions relative to total captures) and found 
some support. For example, Khalil et al. [7], who observed a dilution effect found negative 
relationships between densities of field voles (Microtus agrestis) and bank voles, but only in the 
fall, and only in core field vole habitat. Interestingly, Ecke et al. [11] who observed no effect 
with α diversity (local diversity) but a dilution effect with β and γ diversity, found that when the 
community contribution of bank voles was higher, those of gray-sided voles (Myodes rufocanus) 
were lower. However, not all studies that reported a dilution effect found negative relationships. 
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Tersago et al. [8] detected no relationship between the densities of voles and wood mice 
(Apodemus sylvaticus), although they used proportion of wood mice (instead of their density) as 
their diversity measure (Table 2.1 in main text). Khalil et al. [7] found positive associations 
between densities of voles and other small mammals. In particular, there was a positive 
relationship with field vole density only in spring, and only in certain habitat types. However, the 
positive relationship they detected with density of common shrews (Sorex araneus) was 
irrespective of habitat, or season, suggesting that a dilution effect via shrews is more likely to be 
density-independent.  
When considering all the evidence, the empirical support for host density acting as an 
indirect driver of a dilution effect in the bank vole-PUUV system is not as strong compared to 
the deermouse-SNV system. However, it is likely this is the result of having fewer studies 
available for examination (Table 2.1 in main text). Most of the bank vole-PUUV studies do 
highlight an interesting point, however. Given that particular nonhost species are more likely to 
be the actual drivers of dilution or amplification effects than diversity pe se, it may be better in 
future studies to employ densities of relevant nonhost species (or functional groups of species), 
than broader diversity measures (e.g. [12]), such as small mammal diversity, especially in 
species-poor communities. 
 




                Equation (1a) 
       Equation (1b) 
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where S is the number of susceptible hosts, I is the number of infected hosts, N is the total host 
number (S+I) , K is the number of hosts the environment can sustain, b is the maximum birth 
rate, d is the minimum death rate, a is the proportion of density-dependence on birth rates, r is 
the intrinsic growth of the population (b-d) , µ is the disease-induced mortality rate, and β is the 
transmission rate.  
 
Below are the mathematical equations for the two linear regressions (Figure S2.1) that were used 
in simulations with the susceptible-infected (SI) model above (Equations 1a and b). The linear 
regressions were constructed, as such, to generate realistic values of K and β as reported by Luis 
et al. [13]. 
          Equation (2) 
where K is the environmental carrying capacity of deermice at equilibrium (and thus the density 
that can be sustained), and SDI is the Simpson’s Diversity Index as calculated by Luis et al. [13].  
          Equation (3) 
where β is the transmission rate of SNV for a given deermouse density (the product of contact 
rates and probability of transmission given contact).  
We parameterized the SI model using values estimated previously by Luis et al. [10] 
(Table S2.1) and we tested diversity (Simpson’s Index) values ranging from 1 to 4 as to remain 
within a realistic context [13] and to demonstrate the array of possible outcomes. We used R 
(version 4.0.3, [14]) within RStudio [15] to run simulations over 100 time steps to reach 




Figure S2. 1 : Color-coded relationships used in simulation scenarios whose outcomes are shown 
in figure 2 of the main text. Top left panel: Relationships between diversity and host density. Top 
right panel: Relationships between diversity and transmission rate for a given host density 




Table S2. 1 Variables and parameters used in model with descriptions and estimates. 
Parameter/Variable Value Description 
a 0.6142470 Density-dependent effect on births [10]. 
b 0.3154089 Birth rate of deermouse per capita [10]. 
d 3.655774e-05 Death rate of deermouse per capita [10]. 
µ 0.085 Disease-induced mortality [10]. 
SDI 1 – 4 Average Simpson’s Diversity Index. Values selected 
to represent range reported in [13]. 
 
  
CONSIDERING DISEASE METRICS OTHER THAN ANTIBODY PREVALENCE 
During our literature search, we found that a minority of studies reported two disease metrics 
other than antibody prevalence, including the density of infected hosts and the probability of 
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infection for a given host (i.e. force of infection). In particular, two studies identified contrasting 
relationships between diversity and disease, based on what metric they used [8,17]. Given this 
disagreement, we examined the relationships between diversity and disease, under all simulation 
scenarios, by using these two disease metrics instead of antibody prevalence. Overall, we found 
similar patterns to what we observed with antibody prevalence as the disease metric (Figure 2.1). 
However, we did find that disease risk peaked at lower diversity values with density of infected 
hosts under scenario 3 (Figure 2.2 in main text versus Figure S2.2 below). One of the studies 
[17] found a dilution effect with number of infected hosts but no effect with antibody prevalence. 
Our findings under scenario 3 suggest that, where a dilution effect could be seen with density of 
infected hosts, a neutral relationship could be observed instead with antibody prevalence if there 
was enough stochasticity in the data. Therefore, it is theoretically possible for the same study to 
report two contrasting disease outcomes depending on the disease metric used. However, our 
simulation findings do not explain the opposing conclusions generated by Tersago et al. [8] that 







Figure S2. 2 Conceptual representations of simulation results of diversity-disease outcomes for 
three scenarios where density-dependent (host density) and density-independent (transmission 
rate for a given host density) mechanisms were allowed to vary in their relationship with species 
diversity, using a Susceptible-Infected (SI) model of the deermouse-Sin Nombre virus (SNV) 
system. Instead of antibody prevalence, two other metrics employed by a minority of studies 
found by our review were used: density of infected individuals, and force of infection (i.e. 
probability of infection). Across both disease metrics, scenario 1 (blue) generated dilution, 
scenario 2 (red) amplification, and scenario 3 (black), a non-monotonic relationship, consistent 
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CHAPTER 3 ASSESSMENT OF THE STRESS RESPONSE IN NORTH AMERICAN 
DEERMICE: LABORATORY AND FIELD VALIDATION OF TWO ENZYME 
IMMUNOASSAYS FOR FECAL CORTICOSTERONE METABOLITES1 
 
ABSTRACT 
Stress physiology is commonly employed in studies of wildlife ecology and conservation. 
Accordingly, we need robust and suitable methods to measure stress physiology in the field. 
Fecal cortisol/corticosterone metabolites (FCMs) are now increasingly being used to non-
invasively evaluate adrenocortical activity; a measure of stress physiology. However, 
immunoassays that measure FCMs must be appropriately validated prior to their use and factors 
that can influence FCMs, such as trap-induced stress, must be considered. Deermice 
(Peromyscus maniculatus) are widely used in scientific studies so that developing methods that 
appropriately measure their adrenocortical activity is critical. In the laboratory, we tested the 
suitability of two enzyme immunoassays (EIAs; a corticosterone EIA, and a group-specific 5α-
pregnane-3β,11β,21-triol-20-one EIA) in deermice by challenging individuals with 
dexamethasone and adrenocorticotropic hormone (ACTH). We found that dexamethasone 
suppressed FCM levels within ~10 h post injection whereas ACTH increased FCM levels within 
~2 h post injection. In the field, we found that FCM levels generally increased with more time in 
trap confinement when using both EIAs. Although we acknowledge low sample sizes (N = 4), 




1 This chapter has been published as A. Eleftheriou, R. Palme, and R. Boonstra. 2020 Assessment of the Stress 
Response in North American Deermice: Laboratory and Field Validation of Two Enzyme Immunoassays for Fecal 






In recent decades, researchers have started to employ stress physiology more often as a tool 
to evaluate how natural and anthropogenic stressors can affect survival and reproductive success 
of wildlife populations. Given the widespread use of stress physiology in managing and 
conserving wildlife, identifying suitable and robust methods for evaluating stress physiology in 
every species is of paramount importance. This is critical because anthropogenic stressors can 
induce chronic stress in wildlife, which can lead to pathological perturbations [1,2]. 
Adrenocortical activity, a measure of stress physiology, is typically evaluated via blood 
glucocorticoids (GCs) and more recently via fecal cortisol/corticosterone metabolites (FCMs), 
which are metabolized GCs excreted in feces [2–4]. Evaluation of stress physiology via FCMs is 
non-invasive and avoids the acute stress effects of capture, handling, and venipuncture [1]. 
Although researchers are increasingly using FCMs, there are concerns about the methodology 
used to measure them, such as lack of validation [4]. Immunoassays are validated when they can 
detect expected changes in FCM levels [4]. Without validation, inference becomes less robust. 
Thus, immunoassays need to undergo analytical, physiological, and biological validations before 
they are used to measure FCMs in field settings [4]. Analytical validation may include intra- and 
inter-assay coefficients of variation and parallelism tests [4]. Validations also must be performed 
in every species because suitable immunoassays for measuring FCMs can vary even between 
closely related species [4–6]. 
North American deermice (Peromyscus maniculatus, hereafter deermice) are widely used in 
biomedical (e.g., [7]), physiological (e.g., [8]), and ecological (e.g., [9]) research. Hence, it may 
not be surprising that FCM evaluation in deermice has already been investigated by others where 
a corticosterone radioimmunoassay (RIA; [10,11]) and two corticosterone enzyme 
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immunoassays (EIAs; [12,13]) have been used. Although the RIA was validated before use, the 
EIAs were not, which makes their use questionable [4]. In addition, all assays used antibodies 
that bind to corticosterone, which is the predominant GC in Peromyscus (e.g., [14]). However, 
intact corticosterone is essentially absent from feces so their use may be suboptimal [4]. For 
example, an EIA that used an antibody, which detects FCMs with a 5α-3β,11β-diol structure, 
demonstrated improved FCM detection in house mice (Mus musculus) compared with 
corticosterone EIAs [15]. Nevertheless, corticosterone immunoassays may still detect FCMs, 
albeit to a lesser degree, because of cross-reactivity between the corticosterone antibody and 
FCMs [4]. Commercial corticosterone immunoassays are also relatively easy to acquire and use, 
although expensive [4]. However, commercial RIAs, unlike EIAs, may be less appealing because 
they use radioactive materials and require a licensed laboratory for their use [4,16]. To the best 
of our knowledge, there have been no studies that compared or validated EIAs for measuring 
FCMs in deermice.  
We can physiologically validate immunoassays by using adrenocorticotropic hormone 
(ACTH) and dexamethasone (a synthetic steroid), which increase and decrease endogenous GC 
production, respectively [4]. However, to biologically validate immunoassays, we need to use 
stressors that are biologically relevant to the species of interest. Although immunoassays can be 
validated biologically if they can track diurnal rhythm changes in FCMs, this should be done in 
addition to other biological validations [4], such as live trapping, which can increase FCMs (e.g., 
[17,18]). Knowing when these trap-induced rises in FCMs manifest in feces is also of practical 
use because they can artificially increase FCMs and lead to erroneous results about baseline 
adrenocortical activity [19]. This time delay between blood GCs and the appearance of 
metabolites in feces is species-specific [20]. Specifically, in deermice, [21] found a delay of 4 h 
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before there were trap-induced effects on FCMs, but as they pointed out, the effects could have 
appeared sooner because they did not sample during a shorter interval (<4 h). 
In this study, we had three objectives. Firstly, in the laboratory, we wanted to validate two 
different EIAs in measuring FCMs using physiological challenges (i.e., dexamethasone and 
ACTH injections). The immunoassays were a corticosterone EIA [12] and a 5α-pregnane-
3β,11β,21-triol-20-one EIA (hereafter referred to as the group-specific EIA, [15]). Secondly, 
again in the laboratory, we wanted to use the diurnal rhythm in GC secretion to biologically 
validate both EIAs. Thirdly, in the field, we wanted to investigate temporal effects of trap 
confinement on FCMs using both EIAs to provide additional biological validation.  
MATERIALS AND METHODS 
 
ACQUISITION AND HUSBANDRY OF LABORATORY DEERMICE 
We acquired 4 adult deermice (2 females: 2 males) from McMaster University, Ontario, Canada, 
and transported them to the animal holding facility at the University of Toronto—Scarborough, 
ON, Canada, in April 2016. These deermice were F1 generation offspring from wild deermice 
that were originally captured from Nebraska, USA [8]. All were ear-tagged, weighed, and sexed. 
All deermice were non-reproductive (males were non-scrotal, and females had non-perforate 
vaginas). They were individually housed in polypropylene cages (47 cm × 26 cm × 20 cm) that 
were equipped with a wire bottom and a glass water bottle with a stainless-steel nipple. All cages 
were mounted within a second same-sized cage that was equipped with a fine metal mesh. The 
wire bottom allowed feces and urine to fall through the bottom of the first cage. Though urine 
continued to pass through the fine mesh, the feces did not. This arrangement minimized urine 
contamination of feces and disturbance to the animals [22]. Male and female deermice were kept 
separate on two different but opposite racks within the same animal facility to limit exposure to 
odor from the opposite sex. We provided them with ad libitum water, rodent chow (LabDiet, St. 
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Louis, Missouri, USA) and ample cotton bedding as nesting material. Deermice were housed 
under a 12:12 h dark-light cycle (lights on at 08:00 h) at room temperature (20 ± 5 °C). 
Ventilation fans were positioned in the wall at either end of the holding facility and operated in a 
push-pull method (the fan at one end pulled air out of the facility and the other pushed outside air 
into the facility). This method changed the air in the room 13 times/h. The direction of air flow 
was parallel to cage racks, which prevented cross contamination between cages that held males 
and females [23].  
FECAL SAMPLE COLLECTION 
We collected fecal samples by following Table 3.1 and discarded feces contaminated with 
urine. Forceps were disinfected between individuals during sample collection. If fecal pellets 
were in excess for an individual, we subsampled to get a representative pooled sample from all 
areas where the individual had defecated. We then stored samples at −20°C until analyses. 
During the acclimation period, fecal samples were collected every 2 h (during the dark and light 
cycles) whereas during the challenge experiments, samples were generally collected every 2 h 
during the dark cycle and every 4 h during the light cycle (Table 3.1). This sampling change 
occurred due to personnel constraints. 
ACCLIMATION PERIOD 
 
Fecal samples were collected for ~92 h after the animals were transferred to our facility 
(Table 3.1). We assumed that samples collected on the3 last day of acclimation reflected baseline 
FCMs given that previous work with wild meadow voles (Microtus pennsylvanicus) found that 
FCMs were the lowest by the end of the third day of captivity [24].  
DEXAMETHASONE SUPPRESSION CHALLENGE 
To test whether EIAs could detect an expected decrease in FCM levels, we injected all 
deermice with 2.5 mg/kg dexamethasone sodium phosphate (Vétoquinol, Québec, Canada) 
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diluted in sterile 0.9% saline intraperitoneally at ~20:00 h. In this way, each individual was used 
as its own control. Because dexamethasone doses have not been reported for deermice, we 
formulated this dose based on studies with other small rodents (e.g., [25–27]). We started to 
collect samples at 22:00 h for ~48 h although we were unable to analyze samples 12 h post 
injection (Table 3.1). No samples were collected at the time of injection.  
ACTH STIMULATION CHALLENGE 
To test whether EIAs could detect an expected increase in FCM levels, we injected all 
deermice with 250 µg/ kg ACTH (Cortrosyn, Amphastar Pharmaceuticals, Inc., Rancho 
Cucamonga, CA, USA) mixed in 0.9% sterile saline solution intraperitoneally at ~20:00 h. 
Again, each individual was used as its own control and because ACTH doses have not been 
reported for deermice, we formulated this dose based on above cited studies. As above, we 
started to collect samples at 22:00 h for ~48 h although we were unable to analyze samples 12 h 
post injection (Table 3.1). No samples were collected at the time of injection.  
FIELD VALIDATION 
We carried out two field studies to assess the temporal effect of trap confinement on FCM 
levels. In both studies, deermice were captured in individual non-folding Sherman traps (H.B. 
Sherman Traps, Tallahassee, FL, USA) baited with oats and peanut butter, and provided with 
cotton bedding. In field study 1 (for group-specific EIA), apple slices were also provided. For 
field study 1, we trapped 20 adult deermice (7 males, 13 females) near Drummond, MT, USA, in 
June 2017. Only three were non-reproductive. Once trapped, we confined deermice in a trap for 
either 0–2, 4–6 or 8–10 h prior to processing. To do this, we set traps around dusk and checked 
them after 2 h. Trapped deermice were either processed for the 0–2 h treatment or left in the trap 
to be processed for the 4–6 h and 8–10 h treatments, where they spent an additional 4 h and 8 h 
in the trap, respectively. Deermice were removed from traps by “emptying” contents into a 
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plastic bag. We then sexed, weighed, ear-tagged, and evaluated them for reproductive status. Age 
was determined based on mass (<14 g = juvenile, 14–17 g = subadult, >17 g = adult, [28]). 
Reproductive status was determined by the presence of scrotal testes in males, and presence of a 
perforate vagina, lactation, or pregnancy in females.  
In field study 2 (for corticosterone EIA), seven adult deermice (4 males, 3 females) were 
trapped near Charlo, MT, USA, in August 2017. Only two were non-reproductive. We checked 
traps after ~4 h of setup when we ear-tagged and collected feces from deermice. Afterwards, all 
deermice were returned to their respective clean traps where they spent the night until dawn (an 
additional ~7 h). At that time, they were sexed, weighed, evaluated for reproductive status, and 
sampled a second time for feces. Age and reproductive status were determined as above. 
In both field studies, we collected feces from restrained animals and/or their trap and released 
individuals on site after processing. Feces contaminated with urine were not collected. We 
followed field protocols to avoid accidental hantavirus infection [29]. All fecal samples were 
stored at −80 °C until analysis. All procedures involving animal use were approved by the 
University of Toronto (protocol # 20011602) and/or by the University of Montana Institutional 
Animal Care and Use Committees (protocol #s 024-16ALDECS-042616, 027-16ALDECS-
051016, 028-16ALDECS-051016). Field work was approved by Montana Fish, Wildlife and Parks 
(permit #2017-029-W).  
 
PROCESSING OF FECES AND EXTRACTION OF FCMs 
Laboratory and field study 1 fecal pellets were first oven-dried for 1 h at ~60 °C to heat-
inactivate hantavirus (if present) and then lyophilized (Labconco Corp., Kansas City, MO, USA) 
for at least 15.5 h at Pennsylvania State University, State College, Pennsylvania, USA. 
Laboratory study fecal samples were not pulverized; they remained in pelleted form. However, 
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in field study 1 we did pulverize, using a mortar and pestle, because there were fewer total 
samples (20 samples). To extract FCMs, we weighed 0.05 g (±0.005 g) of dried pellets/powder. 
Then, we added 1 mL of 80% methanol to each sample suspension, vortexed at 1500 RPM for 30 
min, and centrifuged at 2500× g at 22 °C for 20 min [4,15]. Supernatants were decanted and 
frozen at −20 °C. The extraction of field study 2 samples was slightly different and performed at 
the University of Montana, Missoula, MT, USA. Fecal pellets (14 samples total) were heat-
inactivated and oven-dried for 2 h at ~63 °C to ensure elimination of water, because a lyophilizer 
was unavailable. We pulverized dried pellets and weighed out 0.04 g (±0.005 g) of powder. The 
lower threshold weight was chosen because sample weights were generally lower in this field 
study. The rest of the extraction procedure remained unchanged.  
IMMUNOASSAY METHODS 
For the analysis of FCMs two different EIAs were used. The immunoassays were a 
corticosterone EIA (commercial kit #K014-H1 or H5, provided by Arbor Assays, Ann Arbor, MI, 
USA) [12] and a 5α-pregnane-3β,11β,21-triol-20-one EIA (group-specific EIA, measuring FCMs 
with a 5α-3β,11β-diol configuration [15]). Details of the EIAs including cross-reactions are 
given by Arbor Assays and Touma et al. [15], respectively. All fecal extracts were diluted with 
EIA buffer prior to being analyzed. The dilution factor was determined by running pooled sample 
extract at different dilutions against the standard curve, to identify the one that resulted in ~50% 
binding for the corticosterone EIA (Figure 3.1A) and the group-specific EIA (Figure 3.1B). 
Through parallelism tests, we showed that serial dilutions of pooled extract tracked the EIA’s 
standard curve (Figure 3.1). These findings demonstrated that methanol residue in sample extracts 
did not interfere with assay performance. Consequently, sample extracts were diluted 1:10 for the 
corticosterone EIA, and 1:200 for the group-specific EIA. However, extracts from field study 2 
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analyzed with the corticosterone EIA had to be diluted 1:80 instead of 1:10 (change discussed 
later).  
We followed manufacturer’s instructions for the corticosterone EIA. However, when we 
analyzed fecal samples with this EIA for field study 2, we also used a wavelength of 650 nm 
(reference wavelength) in addition to 450 nm. We followed the protocol described by Touma et al. 
[15] for the group-specific EIA. All samples were assayed in duplicate. Intra-assay coefficients of 
variation (CVs) were calculated by averaging all sample CVs and inter-assay CVs were calculated 
by averaging CVs of low and high concentration controls for all plates (except for field study 2, we 
could only calculate average of low concentration controls). Intra-assay and inter-assay CVs for the 
corticosterone EIA were (n = 9) 5.7% and 12.7% (field study 2: 12.8%) and for the group-specific 
EIA (n = 6) 8.6% and 8.6%, respectively.  
STATISTICAL ANALYSES 
All data analyses were done in R [30] within RStudio [31]. We used linear mixed effect 
models (LMMs) from R packages “lme4” [32] and “lmerTest” [33] to test for diurnal patterns 
and how each treatment (dexamethasone suppression and ACTH stimulation) affected FCM 
levels of laboratory-bred deermice compared to baseline. We considered FCMs collected on the 
last day of acclimation as baseline FCMs. Because deermice were sampled repeatedly, individual 
identification was included as a random effect, where the model structure was sex + treatment × 
sampling time, except for when testing for diurnal patterns, which was sex + sampling time. P-
values were calculated using Satterthwaite’s method [33]. We used the R package “emmeans” 
[34] to perform post hoc pairwise comparisons where p-values were adjusted accordingly.  
For field study 1, we used a one-way ANOVA with post hoc Tukey’s Honest Significant 
Differences to compare FCM levels across trap confinement treatments (i.e., 0–2, 4–6 and 8–10 
h), sex and reproductive status, where the model structure was treatment + sex + reproductive 
48 
 
status. For field study 2, we used a LMM to examine the difference between FCMs across two 
sampling times (i.e., 0–4 h vs. overnight), sex, and reproductive status, where the model structure 
was treatment + sex + reproductive status. Because each deermouse was sampled twice, 
individual identification was included as a random effect.  
FCM data were ln-transformed prior to all analyses to meet the assumptions of normality 
and homoscedasticity. Below, we present ln-transformed means with standard errors (ln ng/g of 
dry feces) where we considered results statistically significant at α = 0.05. However, in the 




We did not find changes across sex (p = 0.16) or time (p = 0.10) with the corticosterone EIA 
(Figure 3.2A). Similarly, there were no changes across sex (p = 0.60) or time (p = 0.22) with the 
group-specific EIA (Figure 3.2B). However, it is noteworthy that the variability in FCMs 
appeared smaller towards the end of the dark cycle compared to the beginning. FCMs collected 
during the third day of acclimation were considered as baseline when we evaluated the effects of 
treatments (dexamethasone and ACTH). 
DEXAMETHASONE SUPPRESSION CHALLENGE 
We found a sampling time by treatment effect for the corticosterone EIA (F4, 18.31 = 3.73, p = 
0.02; Figure 3A). Deermice had lower FCM levels (n = 4, 6.23 ± 0.26 ln ng/g) ~10 h post 
injection than baseline (06:00 h, n = 3, 7.54 ± 0.30 ln ng/g, post hoc, t18.32 = −3.37, p = 0.003). 
We also found a sampling time by treatment effect for the group-specific EIA (F4, 21 = 3.39, p = 
0.03; Figure 3B). Deermice had lower FCMs (n = 4, 7.03 ± 0.15 ln ng/g) than baseline ~10 h 
post injection (06:00 h, n = 3, 7.60 ± 0.17 ln ng/g, post hoc, t19.46 = −2.47, p = 0.02). 
Interestingly, deermice showed a marginal increase in FCMs (n = 4, 8.16 ± 0.15 ln ng/g) ~4 h 
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post injection compared to baseline (n = 2, 7.63 ± 0.22 ln ng/g, t20.42 = 1.96, p = 0.06). We note 
that baseline FCM levels at 06:00 h represent a 2 h interval (04:00–06:00 h) whereas treatment 
FCM levels at the same time represent a 4 h interval (02:00–06:00 h; Table 3.1). 
ACTH STIMULATION CHALLENGE 
We found an effect of treatment for the corticosterone EIA (F1, 19.22 = 11.94, p = 0.003; 
Figure 3.4A) where deermice had consistently higher FCM levels (7.77 ± 0.19 ln ng/g) post 
injection than baseline (7.27 ± 0.20 ln ng/g, post hoc, t19.17 = 3.44, p = 0.003). We also found an 
effect of sampling time (F4, 19.19 = 5.42, p = 0.004) where deermice had higher FCM levels at 
22:00 h (7.84 ± 0.23 ln ng/g; t19.07 = 4.06, p = 0.005), 00:00 h (7.74 ± 0.24 ln ng/g; t19.17 = 3.45, p 
= 0.02), and 06:00 h (7.62 ± 0.22 ln ng/g; t19.05 = 3.14, p = 0.04) compared to 08:00 h (6.99 ± 
0.22 ln ng/g) regardless of treatment. Similarly, using the group-specific EIA, we found an effect 
of treatment (F1, 20.25 = 14.16, p = 0.001; Figure 3.4B) where deermice had higher (7.99 ± 0.12 ln 
ng/g) FCM levels consistently post injection than baseline (7.58 ± 0.12 ln ng/g, t20.16 = 3.75, p = 
0.001; Figure 3.4B). Again, we also found an effect of sampling time (F4, 20.28 = 3.42, p = 0.03) 
where deermice had higher FCM levels at 22:00 h (8.02 ± 0.15 ln ng/g) compared to 08:00 h 
(7.48 ± 0.14 ln ng/g, t20.06 = 3.50, p = 0.02) regardless of treatment. We note that baseline FCM 
levels at 06:00 h represent a 2 h interval (04:00–06:00 h) whereas treatment FCM levels at the 
same time represent a 4 h interval (02:00–06:00 h; Table 3.1).  
FIELD VALIDATION 
For field study 1 (group-specific EIA), we found that there was a marginal effect of 
confinement time on FCM levels (F2,15 = 3.38, p = 0.06), which we still elected to explore 
because of likely biological relevance. We found no effect of sex (p = 0.56) or reproductive 
status (p = 0.39). Deermice confined for 4–6 h had marginally higher FCM levels (n = 6, 4 
females and 2 males, 8.33 ± 0.08 ln ng/g) compared to those confined for 0–2 h (n = 7, 4 females 
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and 3 males, 7.90 ± 0.11 ln ng/g, p = 0.07). However, deermice confined for 0–2 h had no 
differences in their FCM levels compared to those of deermice confined for 8–10 h (n = 7, 5 
females and 2 males, p = 0.16) or 4–6 h versus 8–10 h (p = 0.85; Figure 3.5). For field study 2 
(corticosterone EIA), we found a significant effect of confinement time on FCM levels (F1, 10 = 
23.21, p = 0.001). Deermice had lower FCMs (9.12 ± 0.32 ln ng/g) when confined for 0–4 h 
compared to after short-term restraint and overnight confinement (n = 7, 11.10 ± 0.32 ln ng/g, t6 




We provided evidence that validates the use of both the corticosterone and the group-
specific EIAs with FCMs in deermice. In the laboratory studies, both EIAs showed a similar 
decrease and increase in FCMs post dexamethasone and ACTH injections, respectively. Despite 
the group-specific EIA’s ability to detect particular corticosterone metabolites in feces, FCM 
values were comparable to the ones we detected with the corticosterone EIA. Field study 1 
(group-specific EIA) showed that deermice had marginally higher FCM levels when confined for 
4–6 h versus 0–2 h. Field study 2 (corticosterone EIA) more strongly echoed these results where 
deermice had higher FCMs after short-term restraint and confinement more than 0–4 h. Although 
we did not verify whether the stressors we used increased blood corticosterone, we do not think 
this affects our conclusions because of two main reasons. Firstly, the stressors we used have been 
known to influence blood GCs in other species (e.g., [18,35]), and secondly, many other 
validation studies for FCMs were successful without performing this type of verification (e.g., 
[15,36–38]). Although comparing between studies with different extraction and assay protocols 
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is difficult, both EIAs we used consistently detected higher values compared to the 
corticosterone RIA used in previous deermouse studies (e.g., [10,11]).  
DIURNAL RHYTHM AND SEX EFFECTS 
We detected no effects of diurnal rhythm or sex on FCMs with either EIA when using only 
data from the third day in captivity. However, the variability in FCM data was smaller towards 
the end of the dark cycle compared to the beginning, suggesting that if we had FCM data from 
each deermouse for each time point, a significant change over time may have manifested. 
Regardless, we did find higher FCMs at 22:00 h compared to 08:00 h when using pooled data 
from the ACTH challenge for both EIAs. In fact, FCMs were also higher at 00:00 h and 06:00 h 
compared to 08:00 h for the corticosterone EIA. This finding from pooled data is most likely 
because, although treatment FCMs were relatively higher than baseline, they still showed a 
declining trend, similar to baseline FCMs, across the dark cycle. Previous studies with small 
mammals found either a presence or absence of a diurnal rhythm in FCMs (e.g., [24,25]). 
However, when a diurnal rhythm is found, FCM levels will typically rise before the period of 
highest activity and start to decrease closer to the period of inactivity, which is similar to what 
we found [25,39]. This reflects the dynamics of blood GCs before they appear in feces, which is 
governed by a species-specific time delay [4]. This delay can range from 4 h in small mammals 
(e.g., house mice, [15]) to ~24 h in larger mammals [20]. Similarly, [40] found no effect of sex 
on FCM levels in deermice, although [25] detected sex differences in house mice where females 
had higher FCM levels. Due to low sample size of females and males, there may have been an 




SUPPRESSION OF ADRENOCORTICAL ACTIVITY 
We found that FCM levels decreased significantly ~10 h post dexamethasone injection with 
both EIAs. FCMs decreased on average by ~73% and ~43% for the corticosterone and group-
specific EIAs, respectively. This however, could have happened sooner (i.e., ~8 h post injection) 
since we lacked FCM data at 04:00 h. Nevertheless, other rodent studies found FCM levels 
decreased 8-10 h post dexamethasone in house mice [25] and 10–12 h in Norway rats (Rattus 
norvegicus) [41], although injections were given during the light cycle. However, the percentage 
decreases we observed were lower than in Norway rats (~86%; [41]) but higher than in 
Columbian ground squirrels (Urocitellus columbianus) (~33%; [36]), both of which used the 
same group-specific EIA. This could suggest that a higher dexamethasone dose could be used to 
more strongly suppress FCMs in deermice. It is noteworthy that the group-specific EIA did 
detect a marginal increase in FCM levels ~4 h post dexamethasone injection (~69% average 
increase), most likely due to restraint/injection stress. Even if a higher dose may have resulted in 
a larger effect size, both EIAs tracked the expected suppression in FCMs post dexamethasone. 
 
STIMULATION OF ADRENOCORTICAL ACTIVITY 
FCM levels increased ~2 h post ACTH injection and remained elevated when using both 
EIAs. In particular, FCMs on average increased by ~65% and ~50% with the corticosterone and 
group-specific EIAs, respectively. Given that other rodent studies found longer time delays than 
2 h post ACTH injection, such as 5–7 h in Egyptian spiny mice (Acomys cahirinus) [42] and 6–8 
h in bank voles (Myodes glareolus) [43], this finding was unexpected. However, in these studies 
the ACTH injections were given during the light cycle in rodents that are mostly nocturnal, 
which could have affected time delays [15]. Regardless, [44] did find that brown lemmings 
(Lemmus trimucronatus) reached their half maxima FCM values within 2 h of capture, 
anesthesia, and transportation in the field. Similarly, [26] found that fecal radioactivity appeared 
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as early as 2 h in a radiometabolism study of California mice (Peromyscus californicus). 
Nonetheless, in our study, it is still possible that capture and restraint for injection significantly 
decreased gut passage time [4]. The percentage increases we found are much lower than previous 
mammal studies. For example, [36] found ~255% increase post ACTH in Columbian ground 
squirrels using the group-specific EIA. However, [24] found ~56% increase in meadow voles 
using the group-specific EIA. Therefore, the ACTH dose we used may not have been high 
enough to reach a stronger effect. Regardless, the modest yet significant increase in FCM levels 
post ACTH injection provides validation evidence for both EIAs.  
 
TRAP-INDUCED EFFECTS ON FCMs 
Trap confinement for 4–6 h marginally increased FCM levels in free-ranging deermice, 
compared to confinement for 0–2 h but not compared to 8–10 h (field study 1). Similarly, 
deermice confined for 0–4 h had lower FCM levels compared to additional confinement of ~7 h 
and after short-term restraint (field study 2). Although we cannot easily tease apart effects from 
restraint and trap confinement time in field study 2, the findings still provide biological validation. 
Because FCM levels tend to decrease shortly into the active phase [25,39], the elevations we 
observed after 4 h would most likely have been due to trap-induced stress. The lack of difference 
between 0–2 h and 8–10 h could stem from how the stressor of trap confinement remained 
consistent over time so that FCMs eventually returned to baseline. Alternatively, it could be that 
the natural decline of FCMs overnight conflicted with the increase in FCMs from trap-induced 
stress, thereby leading to a lower average FCMs and a larger variability in the data for the 8–10 h 
group (Figure 3.5). Similarly, [21] found no differences in FCM levels between deermice in traps 
for 4–8 h versus overnight, although FCM levels did continue to increase with more trap 
confinement in another deermouse population. Based on field study 1 findings, the lag time 
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between corticosterone in the blood to excretion in the feces may be ~4 h during the period of 
highest activity (i.e., dark cycle). This is similar to what has been reported in another deermouse 
study that used a corticosterone RIA [21]. Although sex and reproductive status can influence 
stress physiology [4], we did not find any effects on FCMs from sex or reproductive status. 
However, this may have been due to low sample sizes, and not a limitation of the EIAs. 
Nevertheless, our findings suggest that trap-induced stress may affect FCM levels even within 4 
h of confinement so that earlier fecal collection may better capture baseline adrenocortical 
activity and unmask individual heterogeneity.  
 
DRYING EFFECTS ON FCMs 
Although samples oven-dried for 1 h and then lyophilized were diluted 1:10 for the 
corticosterone EIA, samples oven-dried for 2 h with no lyophilization had to be diluted 1:80 
instead. This increase in the dilution factor could be the result of additional drying time where 
further alteration of FCMs can affect actual FCM levels and influence antibody binding. Similar 
heat effects on FCM levels were reported by [45] where autoclaving ungulate feces artificially 
increased FCM levels. However, an alternative reason could be the origin of the samples because 
those that were diluted more came from free-ranging deermice whereas those that were diluted 
less came from laboratory deermice on rodent chow diet. Because diet can affect FCM levels, the 
diet of free-ranging deermice may have led to artificially higher FCM levels [46]. However, 
because the group-specific EIA did not detect differences between laboratory and wild deermice 
(i.e., same dilution factor), it is most likely that an additional hour of oven-drying induced 
structural changes to FCMs that were detected by the corticosterone EIA antibody, thereby 
increasing FCM levels (e.g., [47]). Therefore, the drying protocol needs to remain consistent 
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throughout a study, (e.g., for multiple samples from one individual) if valid FCM comparisons 
are to be made. 
CONCLUSIONS 
We analytically, physiologically, and biologically validated two EIAs for measuring FCMs 
in deermice. Although we used identical sample processing and extraction methods for 
laboratory samples, this was not the case with field samples so direct comparisons should be 
made with caution. Nevertheless, both field studies demonstrated similar temporal patterns, so 
they provided biological validation for the two EIAs. Although we acknowledge low sample 
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Table 3. 1 Timeline of treatments and samples used in statistical analyses for evaluation of fecal 
corticosterone metabolites in deermice. 
Date Treatment 1 Immunoassay 
Sample Collection 2 Schedule (h Post 
Treatment) 
May 2–3 Acclimation 
Corticosterone EIA 70, 72, 74, 76, 80, 82 
Group-specific EIA 70, 72, 74, 76, 78, 80, 82 
May 3–4 Adrenal suppression 
Corticosterone EIA 2, 4, 6, 10, 12 
Group-specific EIA 2, 4, 6, 10, 12 
May 5–6 Adrenal stimulation 
Corticosterone EIA 2, 4, 6, 10, 12 
Group-specific EIA 2, 4, 6, 10, 12 
1 Injections administered at ~20:00 h, 2 Acclimation lasted for ~92 h whereas adrenal treatments 










Table 3. 2 Summary of demographic factors and fecal cortisol/corticosterone metabolite (FCM) 










Male No 21034 49709 28676 
Male No 5407 76071 70663 
Male Yes 11224 185928 174704 
Male Yes 4649 91514 86865 
Female Yes 37172 37776 604 
Female Yes 3611 41678 38067 
Female Yes 9704 82299 72595 
1 Reproductive status was determined via scrotal testes in males and presence of a perforate 
vagina, lactation, or pregnancy in females, 2 FCM difference was calculated by subtracting 











Figure 3. 1 Parallelism curves for pooled fecal extract from deermice measured with (A) 
corticosterone enzyme immunoassay (EIA) and (B) group-specific EIA. Standard curves for each 
EIA are shown in black with each concentration as an open diamond. Parallelism is shown in red 

















Figure 3. 2 Changes in corticosterone baseline fecal cortisol/corticosterone metabolites (FCMs) 
from laboratory-bred deermice across the dark cycle measured with (A) corticosterone enzyme 
immunoassay (EIA) and (B) group-specific EIA. Lines connect means from each sampling time 
and circles indicate data points whereby an individual is denoted with a different color. Males are 














Figure 3. 3 Corticosterone baseline fecal cortisol/corticosterone metabolites (FCMs) (solid lines 
and circles) versus post dexamethasone FCMs (dashed lines and triangles) in laboratory-bred 
deermice measured with (A) corticosterone enzyme immunoassay (EIA) and (B) group-specific 
EIA. Lines connect means from each sampling time. Circles and triangles indicate individual 
data points whereby an individual is denoted with a different color. Males are shown in blue and 
green colors, whereas females are shown in red and tan. Dexamethasone was administered at 










Figure 3. 4 Corticosterone baseline fecal cortisol/corticosterone metabolites (FCMs) (solid lines 
and circles) versus post adrenocorticotropic hormone (ACTH) FCMs (dashed lines and triangles) 
in laboratory-bred deermice measured with (A) corticosterone enzyme immunoassay (EIA) and 
(B) group-specific EIA. Lines connect means from each sampling time. Circles and triangles 
indicate individual data points whereby an individual is denoted with a different color. Males are 
shown in blue and green colors, whereas females are shown in red and tan. ACTH was 





Figure 3. 5 Fecal cortisol/corticosterone metabolites (FCMs) across different trap confinement 
times in free-ranging deermice. FCMs were measured with the group-specific EIA. Boxplots 
display the median (line), 25–75% interquartile range (boxes) and the full range (whiskers). In 
the 0–2 h group, there is a large outlier. Circles indicate individual data points whereby blue 















CHAPTER 4 HETEROSPECIFIC COMPETITORS AND SEASONALITY CAN 




Ecological and environmental factors can influence the transmission of infectious diseases. They 
can accomplish this via effects on host susceptibility and exposure to infection, which are 
governed by host physiology and behavior, respectively. To better inform disease control, more 
information is needed about how extrinsic factors affect physiological and behavioral processes 
that determine transmission. We investigated how heterospecific competitors and seasonality 
may influence host susceptibility and intraspecific contact rates using a directly-transmitted 
disease system, the North American deermouse (Peromyscus maniculatus) - Sin Nombre 
hantavirus (SNV) system. In grasslands of western Montana, USA, deermice compete with 
dominant voles (Microtus spp.) and shrews (Sorex spp.) and experience a seasonal temperate 
climate. Higher SNV transmission occurs primarily during spring/summer, when changes in 
physiology and behavior may serve as influential contributors. We hypothesized that: (1) voles, 
and to a lesser extent shrews, will induce chronic stress, suppress immunity, and may change 
contact rates of deermice, and (2) during spring/summer, deermice may experience chronic 
stress, suppressed immunity, and higher contact rates, which may help explain the reported 
seasonality in SNV transmission. Over two years, we trapped small mammals at four grids in 
western Montana. Deermice were sampled for feces and blood and evaluated for scar numbers, 
demography and body condition scores (BCSs). We evaluated stress physiology with fecal 
 
2 This paper is in press in “Ecosphere”. A. Eleftheriou, A. J. Kuenzi and A.D. Luis. 2021. Heterospecific 
competitors and seasonality can influence host physiology and behavior: key factors in disease transmission. 
Ecosphere. In Press.  
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corticosterone metabolites (FCMs), neutrophil/lymphocyte (N/L) ratios and BCSs, immunity 
with white blood cell (WBC) counts, and contact rates with scar numbers. We found that shrew 
density was negatively associated with stress response FCMs, suggestive of chronic stress. 
Additionally, although complex interactions existed, shrew and vole densities were negatively 
associated with BCSs, but differentially with scar numbers. N/L ratios were higher in 
spring/summer whereas WBC counts were lower in summer, suggestive of chronic stress and 
suppressed immunity, respectively. Our results suggest that (1) heterospecific competitors may 
differentially influence disease transmission via stress physiology and contact rates, and that (2) 
chronic stress, suppressed immunity, and higher contact rates may help explain why higher SNV 
transmission has been previously reported during spring/summer in Montana. Our findings may 
extend to other directly-transmitted disease systems.  
 
INTRODUCTION 
Globally, emerging infectious diseases are causing wildlife populations to decline and species to 
go extinct (Daszak et al. 1999, Williams et al. 2002, Smith et al. 2006). Extrinsic (i.e., ecological 
and environmental) factors may drive a rise in disease emergence, because they can influence 
two key determinants of disease transmission. These include host susceptibility and exposure to 
infection, which are governed by host physiology and behavior, respectively (Hawley et al. 
2011). Therefore, to better inform wildlife conservation and disease management, it is imperative 
that we identify physiological and behavioral mechanisms that link extrinsic factors to disease 
transmission so we can better understand and predict their impacts on wildlife disease dynamics. 
Extrinsic factors may impact host physiology via glucocorticoid (GC) hormones, crucial 
regulators of the stress response. Although an acute rise in GCs from a stressor is considered 
adaptive, persistently elevated GCs (i.e., chronic stress) are maladaptive because they can lower 
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immunity and increase susceptibility to infection (Dickens and Romero 2013, Dantzer et al. 
2014). Stress physiology is typically evaluated with blood GCs but also with metabolized GCs in 
feces called fecal cortisol/corticosterone metabolites (FCMs) (Palme 2019). When vertebrates 
experience chronic stress, their baseline FCMs can rise and their stress response to an acute 
challenge (i.e., stress response FCMs) can decline (Busch and Hayward 2009). However, GC 
secretion patterns can be highly variable, which can make interpretation of hormone data a 
cumbersome task. Therefore, it is best practice to employ several measures that span GC 
metabolism (i.e., downstream effects of GCs) to attain a more comprehensive evaluation of stress 
physiology (Breuner et al. 2013, Dantzer et al. 2014).  
There are various downstream measures of GCs (reviewed in Breuner et al. 2013). For 
example, because GCs increase neutrophils and decrease lymphocytes in the peripheral 
circulation, individuals under chronic stress are expected to have higher neutrophil/lymphocyte 
(N/L) ratios (Davis et al. 2008), while they are expected to have lower body condition scores 
(BCSs) from GC-induced breakdown of fat and muscle reserves (Sapolsky et al. 2000). 
However, the effect of GCs on immunity is much less straightforward because components of 
the immune system (e.g., humoral versus cellular) may respond differently to chronic stress 
(Sapolsky et al. 2000). Despite this inherent complexity, total white blood cell (WBC) counts are 
largely expected to decline with chronic stress (Martin 2009).  
Heterospecific competitors may influence host susceptibility and exposure to infection. In 
particular, competitors may increase host susceptibility to infection via GCs. For example, 
Santicchia et al. (2018) found that invasive grey squirrels (Sciurus carolinensis) increased 
baseline FCMs in Eurasian red squirrels (Sciurus vulgaris), and Narayan et al. (2015) showed 
that invasive cane toads (Rhinella marina) decreased body condition in Fijian ground frogs 
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(Platymantis vitiana). Therefore, interspecific competition can influence stress physiology, and 
presumably, host immunity. Additionally, heterospecific competitors may alter host behavior, 
thereby affecting exposure to infection. For example, Glass and Slade (1980) found that prairie 
voles (Microtus ochrogaster) avoided space that was used by reproductive cotton rats (Sigmodon 
hispidus), and Gutman and Dayan (2005) found that common spiny mice (Acomys cahirinus) 
inhibited the nocturnal activity of golden spiny mice (A. russatus). Taken together, heterospecific 
competitors may influence disease transmission via both host physiology and behavior.  
Environmental factors that fluctuate seasonally, such as food availability and ambient 
temperature, may influence stress physiology, immunity, and behavior, which may explain why 
disease prevalence can vary seasonally in wildlife hosts (Altizer et al. 2006). Particularly in 
temperate habitats, seasonal environmental factors can affect stress physiology and immunity of 
wildlife, which may have ramifications for disease transmission (Nelson and Demas 1996). In 
fact, most vertebrates undergo seasonal changes in baseline and stress-induced GCs, with higher 
baseline GCs expected during the breeding period, although this can be species-specific (Reeder 
et al. 2005, Romero et al. 2008). Similarly, vertebrates undergo seasonal changes in immunity. 
For example, birds and small mammals enhance their immunity in winter (Martin et al. 2008). 
Wildlife can also exhibit seasonal changes in behavior that may affect disease transmission. For 
example, by aggregating in flocks during winter, house finches may experience seasonal 
exposure to Mycoplasma gallisepticum (Altizer et al. 2004), and by engaging in aggressive 
interactions during their breeding season, bank voles (Myodes glareolus) may experience 
seasonal exposure to Puumula hantavirus (Escutenaire et al. 2002). In summary, seasonality in 
environmental factors may impact disease transmission via host physiology and behavior. 
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To examine physiological and behavioral links between extrinsic factors and mechanisms 
affecting disease transmission, we conducted an observational study in grasslands of western 
Montana, USA, with the North American deermouse (Peromyscus maniculatus; hereafter 
deermouse), the reservoir host for the directly-transmitted Sin Nombre hantavirus (SNV). This is 
an appropriate system for examining how physiology and behavior may link extrinsic factors to 
transmission for two main reasons. Firstly, there has been considerable research regarding the 
“diluting” effect of species diversity on disease risk (i.e. dilution effect; sensu Keesing et al. 
2006) across rodent-hantavirus systems (e.g., Suzán et al. 2009, Dearing et al. 2015, Khalil et al. 
2016). However, the dilution effect observed may not be due to diversity per se but due to 
ecological processes, such as interspecific competition between host and nonhost species, which 
may happen to correlate with diversity (Johnson et al. 2015). Regardless, we still require more 
information about the physiological and behavioral mechanisms behind the dilution effect that 
may be applicable to other directly-transmitted disease systems (Rubio et al. 2017, Luis et al. 
2018). Secondly, although seasonality has been extensively studied as a crucial driver for disease 
dynamics across rodent-hantavirus systems (Luis et al. 2015, Voutilainen et al. 2016), potential 
physiological and behavioral mechanisms have received comparatively less attention. Therefore, 
we used the deermouse-SNV system as a model to investigate how ecological and environmental 
factors affect physiological and behavioral mechanisms of disease transmission.  
At our study site, deermice experience a temperate climate with strong seasonality and 
coexist with voles (Microtus spp.) and shrews (Sorex spp.). This study system allowed us to 
examine how heterospecific competitors (i.e., voles and shrews) and seasonality associated with 
measures of deermouse physiology (i.e., stress physiology and immunity) and behavior (i.e., 
contact rates), which has implications for SNV transmission. Given that demography, parasites, 
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and habitat may influence physiology and behavior, they were also accounted for in our analyses 
(Dantzer et al. 2014). 
Voles are considered dominant competitors of deermice. For example, Grant (1971) 
found that meadow voles excluded deermice from grasslands through aggressive interactions. 
However, we found no evidence to suggest that shrews are also dominant over deermice, and 
because of their much smaller size, we reasoned that they are most likely less dominant. 
Consequently, we hypothesized that dominant voles will induce chronic stress, depress immunity 
and/or alter contact rates of deermice, with shrews having a lesser effect (Table 4.1). We did not 
have a priori hypotheses as to how contact rates may be altered because previous field studies 
generated inconsistent findings (Clay et al. 2009, Rubio et al. 2017, Luis et al. 2018).  
In Montana, SNV transmission is typically highest during spring/summer, which 
coincides with the breeding season of deermice during which they will engage in aggressive 
intraspecific encounters, leading to the accumulation of scars (Douglass et al. 2001, Bagamian et 
al. 2012). Field studies from nearby Idaho, suggest that stress physiology of deermice varies 
seasonally given that deermice were found to have lower FCMs during fall than summer (Harper 
and Austad 2001). Deermouse immunity may also vary seasonally as indicated through 
laboratory experiments where deermice under short-day conditions (i.e., mimicking winter 
conditions in North America), had higher WBC counts compared to long day conditions (Blom 
et al. 1994). Given all the evidence above, we also hypothesized that deermice will experience 
chronic stress, suppressed immunity, and higher contact rates during spring/summer (Table 4.1).  
MATERIALS AND METHODS 
STUDY SYSTEM 
Deermice are the primary reservoir for SNV in North America (Childs et al. 1994). At grasslands 
in western Montana, deermice coexist with few other small mammals, which include meadow 
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(Microtus pennsylvanicus) and montane voles (Microtus montanus), and vagrant (Sorex vagrans) 
and montane shrews (Sorex monticolus; Carson et al. 2006). None of these small mammals are 
considered to be competent SNV hosts (Mills et al. 2010).  
VARIABLES MEASURED 
We evaluated stress physiology with four measures that span GC metabolism: (1) baseline FCM 
levels, (2) stress response FCM levels (FCMs after overnight trap confinement minus baseline), 
(3) N/L ratio, and (4) BCS. Immunity was evaluated with total WBC counts. We used number of 
scars to evaluate contact rates because positive correlations between presence of scars and SNV 
infection in deermice have been found (e.g., Douglass et al. 2001). Despite its limitations, we 
thought number of scars was suitable for two reasons: (1) SNV is primarily directly transmitted 
via bites that can result in scars (Mills et al. 1999, Warner et al. 2019), and (2) it allowed us to 
incorporate a measure of contact rates, which are notoriously difficult to quantify in the field.  
SITE DESCRIPTION AND LIVE-TRAPPING 
Four 1-hectare grids were established, where each grid had 100 trap stations 10 m apart in a 10 X 
10 array (Kuenzi et al. 2001). These were located at the Ninepipe Wildlife Management Area, 
Montana, USA, and were at least 1600 meters away from each other. The most common grasses 
were intermediate wheatgrass (Agropyron intermedium), smooth brome (Bromus sp.) and 
timothy grass (Phleum pratense) (see Supplementary Information for more grid descriptions).  
Small mammals were live-trapped November 2016 - August 2018. Grids A and B were 
trapped October - November 2016, February - December 2017 (excluding June and July for A, 
and July for B) and March - July 2018. Grids C and D were trapped from October - November 
2017 and March - August 2018. We trapped two grids concurrently at a time (i.e., grids A and B 
together, grids C and D together) once a month for three nights. We initially removed voles from 
grid B by euthanasia August 2017 - April 2018, so we could assess removal effects on deermice 
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(Vole N removed = 25). However, we considered this approach to be unsuccessful because voles 
were trapped consistently despite removal. Although removal may have influenced vole 
densities, we still typically trapped voles most often at this grid (Fig. 1). Therefore, we still had 
enough variation in vole densities to address our competitor hypotheses. We speciated 
euthanized or dead voles by examining their dentition; meadow voles have an extra cusp on their 
upper middle molar (Hall and Kelson 1959). We did not speciate shrews but, most likely, they 
were vagrant and montane shrews (Carson et al. 2006).  
We baited non-folding Sherman live traps (H. B. Sherman, Tallahassee, Florida, USA) 
with peanut butter and oats and supplied them with polyester bedding. Traps were opened around 
dusk and checked approximately four hours later when trap-induced stress is less likely to 
influence baseline FCMs (Harper and Austad 2001, Eleftheriou et al. 2020). Voles and shrews 
were released after processing, whereas deermice were returned to their traps so they could be 
processed again around dawn before release on site. This allowed evaluation of the FCM 
response to an acute stressor (i.e. trap confinement; Eleftheriou et al. 2020).  
ANIMAL SAMPLING 
At the initial check, traps that contained animals were taken to a central station for processing. 
We tagged deermice with metal ear tags (National Band and Tag Co., Newport, Kentucky, 
USA), collected feces and returned them to their traps until around dawn, which is when we 
collected more feces and blood, and also weighed them. Sex, presence of fleas and reproductive 
status were also noted. A BCS was estimated between one minus and five plus by palpation of 
tissue at the base of the tail, with five plus being extremely obese (Ullman - Culleré and Foltz 
1999). BCS estimation was performed by the same experienced investigator throughout the 
entire course of the study. We also examined deermice for scars, which we counted, if present. 
We assigned deermice to four scar categories starting in April 2017: (0) no scars, (1) ≤ 4, (2) 5-8 
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and (3) ≥ 9 scars. Age was estimated from weight (juveniles < 14 g, subadults 14-17 g and adults 
> 17 g; Fairbairn 1977). Voles were ear tagged, weighed, sexed and evaluated for BCS and 
reproductive status. Given that shrews cannot be ear tagged, we began marking them in April 
2017 with a permanent marker. Because recaptures of marked shrews were rare (two recaptured 
April 2017 - August 2018), we are confident we did not count the same animals twice within the 
same trapping session. Active reproductive status in female rodents was determined via the 
presence of a perforate vagina, pregnancy and/or lactation, and in male rodents via the presence 
of scrotal testes. Blood was collected with heparinized capillary tubes (Fisher Scientific, 
Pittsburgh, Pennsylvania, USA) from the retroorbital capillary sinus, after topical anesthesia with 
proparacaine (Akorn, Inc., Lake Forest, Illinois, USA). Blood and feces were immediately 
frozen. We followed safety guidelines for working with animals potentially infected with 
hantavirus (Mills et al. 1995). All animal procedures were approved by the Institutional Animal 
Care and Use Committee (# 027-16ALDECS-051016) at the University of Montana, Missoula, 
MT. Land access was granted by Montana Fish, Wildlife and Parks. 
FCM ANALYSES 
We heated feces in a laboratory oven within a biosafety cabinet at ~ 63ºC for two hours to 
inactivate any SNV (J.N. Mills, personal communication) and reach constant weight. Dried feces 
were ground into powder and 0.040 (+/- 0.005) g was weighed out for extraction. One ml of 80% 
methanol was added to powdered samples, vortexed for 30 minutes at 1500 rpm, and centrifuged 
for 20 minutes at ~ 2500g (Eleftheriou et al. 2020). Supernatants were frozen until analyses. 
Because corticosterone is the main glucocorticoid in Peromyscus maniculatus (e.g., Bradley and 
Terman 1981), we quantified FCMs using a corticosterone enzyme immunoassay (EIA) after 
supernatants were diluted (typically 1:80). We followed manufacturer’s instructions (Assay 
Designs, Ann Arbor, Michigan, USA) but also used a reference wavelength of 650 nm. This EIA 
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has been validated with deermouse feces (Eleftheriou et al. 2020). Intra-assay and inter-assay 
coefficients of variation were less than 15% and 20%, respectively.  
WBC COUNT ANALYSES 
In healthy deermice, the most common WBCs in circulation are lymphocytes and neutrophils 
(Schountz et al. 2014). To evaluate WBCs, we followed methodology by Eleftheriou and Luis 
(2020). We stained blood smears with Modified Wright stain (Sigma-Aldrich, St. Louis, 
Missouri, USA) and counted WBCs using light microscopy. Total WBC counts were estimated 
by counting cells from the feathered edge towards the smear’s center for 20 fields at 400X. The 
mean count of 20 fields was multiplied by 2000 to get an estimate of cells/µL. At 1000X, we 
counted lymphocytes, neutrophils, monocytes, eosinophils and basophils out of 100 WBCs. 
SNV ANTIBODY DETECTION 
Because deermice never resolve SNV infections, antibodies are a reliable marker of infection 
(Mills et al. 1999). Therefore, we detected infected deermice by the presence of SNV antibodies 
in blood samples. We coated 96-well plates with SNV recombinant nucleocapsid antigen and 
followed an enzyme-linked immunosorbent assay (ELISA) protocol (Schountz et al. 2007) to 
determine antibody presence.  
STATISTICAL ANALYSES 
To examine seasonal effects, months were grouped to create a season variable where we 
assigned October - February to fall/winter, March - May to spring, and June - August to summer. 
We also grouped juveniles with sub-adults into one group we called non-adults to increase 
sample size. Minimum number alive (MNA) was used as an index of deermouse and vole 
densities (sensu Krebs 1966) because it works well for small mammals (e.g., Luis et al. 2010). 
Number of unique captures was used as an index for shrew densities. We used linear and 
generalized mixed effect regression trees, which use model-based recursive data partitioning, 
where each tree node is a regression coefficient (Fokkema et al. 2018). When individuals were 
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sampled more than once, tag number was a random effect. We considered regression trees as 
appropriate because they can easily handle and identify complex interactions among many 
potential predictor variables that could be overlooked with traditional statistical approaches that 
use stepwise variable selection (Strobl et al. 2009). We used linear mixed effect trees for each of 
these response variables: baseline FCMs, BCSs, N/L ratios, and WBC counts. For scar numbers, 
we used a generalized linear mixed effect tree with a Poisson error structure (Fokkema et al. 
2018). However, for stress response FCMs, we used a generalized linear tree with a Gaussian 
error structure and no random effects because deermice were sampled only once (Hothorn and 
Zeileis 2015). The trees included the following predictor variables: deermouse, vole, and shrew 
densities, trapping grid, season, reproductive status, age, sex, flea presence and SNV infection 
status. Statistical significance was set to α = 0.05. Back transformed means with standard errors 
are presented. We performed analyses in R (R Core Development Team 2018) within R Studio 
(RStudio Team 2015), using R package “glmertree” (Fokkema et al. 2018) to build mixed effect 
regression trees and R package “partykit” (Hothorn and Zeileis 2015) to build generalized linear 
trees. All response variables except stress response FCMs, BCSs and scar numbers were natural 
log transformed to meet normality and homoscedasticity assumptions. We excluded any extreme 
outliers that were identified during this process and noted below whenever this was done.  
RESULTS 
LIVE-TRAPPING 
We captured 289 individual deermice (1028 captures) and 152 individual voles (211 captures). 
Additionally, we had 131 shrew captures. There was variability in animal densities across space 
and time (Figure 4.1). Nearly all voles identified to species were meadow voles (~93%, n = 27).  
STRESS PHYSIOLOGY MEASURES 
We only found a temporal effect on baseline FCMs. Deermice had higher FCMs in fall/winter 
2017 (12030.13 ± 1503.06 ng/g, n = 149, P < 0.001) compared to other times (7547.49 ± 
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1112.90 ng/g, n = 307). Initially, only presence of shrews was associated with lower stress 
response FCMs (19526 ± 2614 ng/g, n = 61, P < 0.001). However, after removing one extreme 
outlier (174703.9 ng/g) the more nuanced effect of shrew density was apparent (Figure 4.2). 
Shrew density > 4/ha was then associated with lower stress response FCMs (10565 ± 3201 ng/g, 
n = 14, P= 0.01). When shrew density was 1- 4/ha, deermice had higher stress response FCMs 
(21537 ± 3071 ng/g, n = 49). However, deermice had even higher stress response FCMs when 
shrews were absent (31612 ± 3471 ng/g, n = 67, P = 0.04). In summary, as shrew density 
increased, stress response FCMs decreased, indicative of chronic stress with a higher shrew 
density.  
 Significant predictors for N/L ratio were season, grid, and age (Figure 4.3). N/L ratios 
were lowest in deermice at grid A (0.42 ± 0.05, n = 61) compared to other grids (0.70 ± 0.10, n = 
115, P = 0.002), only in fall/winter. In spring/summer, adults had higher N/L ratios (1.43 ± 0.18, 
n = 279, P < 0.001) compared to non-adults (0.69 ± 0.15, n = 22).  
Significant predictors for BCS were reproductive status, shrew and vole densities, season, 
and age (Figure 4.4). Non-reproductive deermice had higher BCSs (3.07 ± 0.05, n = 138, P < 
0.001) when shrew density was ≤ 1/ha. When shrew density was > 1/ha, BCSs were lower (2.79 
± 0.09, n = 76). Reproductive non-adults had higher BCSs (3.18 ± 0.12, n = 27, P = 0.001) than 
reproductive adults. For adults, the presence of voles had a significant effect on BCSs (P< 
0.001), and was associated with a temporal effect, where deermice had lower BCSs in spring and 
summer 2018 (2.34 ± 0.08, n = 116), compared to other times (2.64 ± 0.08, n = 109, P=0.002). 
When voles were absent, higher shrew density (˃ 1/ha) was associated with lower BCSs (2.28 ± 
0.12, n = 37), compared to lower density (≤ 1/ha; 2.92 ± 0.11, n = 46, P < 0.001). In summary, 
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deermice had lower BCSs when heterospecific competitors were present, and reproductive adults 
had lower BCSs compared to other age/reproductive classes.  
IMMUNITY 
Significant predictors for WBC counts were grid and season. Deermice at grids A and B had 
lower WBC counts compared to grids C and D (P<0.001; Figure 4.5), which is most likely a 
temporal artifact of which grids were trapped together every month. For all grids, WBC counts 
were higher (A and B: 2239.37 ± 139.00 /µl, n = 230; C and D: 3273.81 ± 340.23/µl, n = 118) in 
fall/winter and spring, and lower in summer (A and B: 1511.72 ± 146.38 /µl, n = 81; C and D: 
2271.31 ± 295.96 /µl, n = 52, P = 0.002). To meet the normality assumption, we had to exclude 
two outliers that had counts of 100 WBCs each from grids A and B. 
SCAR NUMBERS 
Significant predictors for scar numbers were season, vole and shrew densities, and reproductive 
status. Deermice had more scars in spring 2018 and across both summers, compared to spring 
2017 and fall/winter 2017 (P < 0.001; Figure 4.6). During spring and fall/winter 2017, 
reproductive deermice had more scars (1.20 ± 0.17, n = 94) than non-reproductive individuals 
(0.85 ± 0.09, n = 115, P = 0.04). In spring 2018 and both summers, intermediate vole density (1- 
3/ ha) was associated with more scars (2.33 ± 0.28, n = 96, P < 0.001), compared to when voles 
were absent or at a higher density (> 3/ha; 1.59 ± 0.20, n = 101, P =0.001). Shrews only mattered 
when voles were absent; then, with a shrew density > 1/ha, deermice had more scars (2.13 ± 
0.30, n = 45) than when shrew density was ≤ 1/ha (1.53 ± 0.22, n = 58, P = 0.013). Taken 
together, the identity of heterospecific competitors was important in how number of scars in 
deermice were affected. 
SNV INFECTION 
We detected 23 infected deermice with most of them (n=21) from grids where voles were also 
trapped. All, except for one, were trapped August 2017 - August 2018 (Figure 4.1). Because of a 
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low number of infected deermice, there was not enough power to perform formal statistical tests 
for evaluating competition or seasonality effects on SNV prevalence. 
DISCUSSION 
We showed that two key determinants of SNV transmission, host susceptibility and exposure to 
infection, were associated with ecological and environmental factors. In particular, we examined 
how heterospecific competitors and seasonality associated with: (1) stress physiology and 
immunity (i.e., host susceptibility), and (2) scar numbers (i.e., host exposure to infection) in 
deermice. Broadly, we found significant associations between both factors and select measures 
of stress physiology, immunity, and contact rates (summarized in Table 4.1).  
Unfortunately, a low number of SNV-infected deermice, made it difficult to evaluate 
direct relationships between SNV prevalence or transmission with any of our physiological and 
behavioral measures. This was not surprising given the low deermouse densities at our site 
during the study. Deermouse density varies widely over space and time and has been shown to 
be the main driver of SNV prevalence (Luis et al. 2015; 2018). The densities at our field site 
ranged between 2 and 32 deermice/ha (Figure 4.1), with most hovering around the critical host 
density needed for SNV to invade (estimated at ~ 17 deermice/ha at another site in Montana; 
Luis et al 2015). Given the deermouse densities observed, we would expect to see, at most, one 
infected individual when using the epidemiological model of Luis et al. (2015), which is similar 
to what we observed (maximum of three infected individuals per any given month). Although 
deermouse density appears to be the most important driver of SNV prevalence, Luis et al. (2018) 
showed that species diversity can also affect the SNV transmission rate (for a given deermouse 
density), with SNV transmission rate higher in communities with more diverse heterospecific 
competitors. However, Luis et al. (2018) could not discern if this increase in transmission rate 
was due to changes in host susceptibility or contact rates. Here, we present evidence that 
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heterospecific competitor densities may induce chronic stress, which could potentially result in 
suppressed immunity and increased susceptibility to infection. We also present evidence that 
competitors may potentially alter contact rates, which could impact exposure to infection, as 
evidenced by changes in scar numbers.  
INTERSPECIFIC COMPETITION 
We found evidence that heterospecific competitor densities were associated with chronic stress 
in deermice. Shrews were associated with two stress measures (stress response FCMs and BCSs) 
and voles were associated with one (BCSs). Although we hypothesized, based on support from 
the literature, that voles are dominant over deermice, we reasoned that shrews are most likely 
less dominant given the lack of evidence to suggest otherwise. Thus, we expected shrews to 
minimally influence deermouse stress physiology, but we found that shrew density, and not vole 
density, was negatively associated with stress response FCMs, indicative of chronic stress at a 
higher shrew density. Because shrew and deermouse diets can overlap (i.e., insects, Rychlik and 
Jancewicz 2002, Witmer and Moulton 2012), exploitative competition may be intense enough to 
induce chronic stress in deermice. In contrast to our findings, we expected to see an effect of 
voles on deermouse baseline FCMs because: (1) they are dominant over deermice, and (2) a 
positive correlation between vole densities and deermouse baseline FCMs has been found 
previously (Fredebaugh et al. 2013). However, we may have missed an effect because we did not 
sample frequently enough (e.g., weekly) or the effect was too subtle to detect. The absence of 
changes in N/L ratios was also unexpected but may have been due to the aforementioned 
reasons.  
Both vole and shrew densities were negatively associated with body condition scores 
(BCSs) in deermice. BSCs are one measure of chronic stress. However, they could indicate 
lower food availability; another potential result of interspecific competition. Regardless of the 
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cause, individuals with lower BCSs may be more susceptible to infection (Beldomenico et al. 
2009). We found that the presence of voles, and higher shrew density, were associated with 
lower BCSs in reproductive adults only. However, shrew density was associated with larger 
changes (Figure 4.4). This pattern may ensue if reproductive adults compete with voles and 
shrews relatively more, perhaps due to their higher energetic demands. 
Despite associations between heterospecific competitors and stress physiology, we found 
no association with WBC counts, the immunity measure. The complex and multifaceted 
relationship between stress physiology and immunity makes it difficult to choose the best suited 
immune measure that can capture the desired response (Martin 2009). Although relatively cheap 
and simple to attain, WBC counts may increase in response to infection or inflammation, 
potentially masking stress-induced reductions (Davis et al. 2008). Nevertheless, our findings 
suggest that we may need to explore other immunity measures that are more functional in nature, 
such as lymphocyte proliferation assays, which allow for a real-time immune challenge (Demas 
et al. 2011). 
We also found that vole and shrew densities were differentially associated with 
deermouse scar numbers, primarily during the breeding period. Interestingly, the relationship 
between vole density and scar numbers was non-monotonic. Deermice had the most scars at 
intermediate vole densities (between 1 and 3/ha), with fewer scars either when voles were absent 
or present at densities > 3/ha (Figure 4.6). However, at higher shrew densities (>1/ha), deermice 
had more scars than when shrews were absent. Although we did not have clear a priori 
predictions on how contact rates might change in response to interspecific competition, our 
findings suggest that deermice may change their behavior based on what competitor is present. 
Such behavioral changes were reported by Clay et al. (2009) in deermice from Utah, USA, at 
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sites with high small mammal diversity, although Rubio et al. (2017) found no change in 
deermice kept in outdoor enclosures with dominant Merriam's kangaroo rats (Dipodomys 
merriami). We acknowledge that using scar numbers as a proxy for contact rates has limitations 
(e.g., wounds healed with no scars), so our findings related to this measure need to be evaluated 
with caution. Thus, controlled experiments where technology is used to better estimate contact 
rates are needed (e.g., Dearing et al. 2015).  
In summary, our findings suggest that identity of competitor species may matter in how 
transmission is affected because deermouse physiology and behavior responded differently to 
vole and shrew densities. Studies of other disease systems have demonstrated the importance of 
species identity in affecting disease transmission in the focal host, such as with Lyme disease 
(vector-borne transmission, LioGuidice et al. 2003) and chytridiomycosis (environmental 
transmission, Venesky et al. 2013). However, our study is one of the few to examine 
consequences of competitor species on both physiological and behavioral traits of the host that 
have implications for transmission of directly-transmitted diseases. Given our results, it is crucial 
that we continue to test how heterospecific competitors can differentially affect host physiology 
and behavior so we can improve how we understand and predict disease dynamics across diverse 
communities.  
SEASONALITY 
There was no clear seasonality (consistent between years) in baseline or stress response FCMs. 
Although seasonal variation in photoperiod necessarily affected how long deermice were in 
overnight confinement, this did not appear to be influential for stress response FCMs because 
season was not selected as a predictor (Figure 4.2). Our findings are not entirely surprising 
because a review by Romero (2002) found no consistent seasonal patterns in baseline or stress-
induced FCMs (i.e., after trap confinement) in mammals.  
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 We found seasonality in N/L ratios, where deermice had higher N/L ratios in 
spring/summer compared to fall/winter. Seasonal environmental factors that influence GCs may 
also affect N/L ratios, although these two measures may evaluate the stress response differently 
across time (Davis et al. 2008, Goessling et al. 2015). However, inflammation and infection may 
also affect N/L ratios (Davis et al. 2008). Given that deermice were not tested for infection other 
than with SNV, we cannot discern if the seasonality observed was explicitly due to GCs. 
However, given the large sample size and consistent pattern across years, seasonality in stress 
physiology is a more parsimonious explanation. It is noteworthy that seasonal variation in 
photoperiod necessitated that time in confinement also varied by season. Although this may have 
influenced the findings, seasonality in N/L ratios (or heterophil to lymphocyte ratio in birds and 
reptiles) has been observed in other vertebrates (e.g., Norte et al. 2009, Goessling et al. 2016). In 
contrast to N/L ratios, we did not find clear seasonality in BCSs, despite seasonal changes in 
body condition occurring in other vertebrates (e.g., Milenkaya et al. 2013, Pokharel et al. 2017).  
 There was clear seasonality in the immunity measure, WBC counts, which were higher in 
fall/winter and spring, but lower in summer. Similar to N/L ratios, inflammation or infection may 
also influence WBC counts and possibly time in confinement as well (Davis et al. 2008). 
However, evidence consistent with our field data from previous studies of small mammals, 
including deermice, propose that seasonality is the most likely parsimonious explanation for our 
findings (Blom et al. 1994, Martin et al. 2008). 
 Aggressive encounters between deermice that lead to scars are associated with breeding 
and typically occur in spring/summer (Bagamian et al. 2012). Similar changes in scarring from 
intraspecific fights occur seasonally in other vertebrates (Christian 1970, Woodroffe and 
Macdonald 1995). Such seasonal changes in aggressive encounters can result from changes in 
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home range dictated by reproduction and food availability (e.g., Perelberg et al. 2003). For the 
most part, our study confirms this pattern. We also observed that deermice had more scars across 
summers and spring 2018 compared to fall/winter. However, lower scar numbers in spring 2017 
did not fit this pattern. Perhaps food availability, which we did not measure, was greater in 
spring 2017, which may have led to fewer aggressive encounters.   
Taken together, higher N/L ratios in spring/summer, lower WBC counts in summer, and 
more scar numbers in summer, may provide valuable insight as to why previous studies in 
Montana found that SNV transmission is higher in spring/summer. However, experimental 
studies would be needed to causally link these findings to SNV transmission in deermice.  
CONCLUSIONS 
Overall, we found evidence that heterospecific competitors and seasonality were 
associated with select physiological and behavioral measures in deermice. However, we found 
no effects of deermouse density, which was surprising given that density has been associated 
with stress physiology and intraspecific contact rates in rodents (Harper and Austad 2004, 
Ostfeld and Keesing 2019). Similarly, there were no effects from flea infestation or SNV 
infection (although we very likely lacked power to detect an effect). Absence of these 
associations suggests that neither deermouse density nor parasitism were as important as 
heterospecific competitors and seasonality in affecting physiological and behavioral measures. 
However, if deermouse density were high enough for a long enough duration to sustain SNV 
transmission and increase infection, perhaps those associations could manifest. We should note 
that because we did not measure temporal or spatial heterogeneity in vegetation cover across 
grids, we cannot ascertain its consequences on physiological and behavioral measures. However, 
because grid was not a significant predictor in most models, it seems likely that vegetation cover 
itself did not play a widely influential role.   
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The mechanistic approach of our study can inform other disease ecology studies that seek 
to identify potential physiological and behavioral links between extrinsic factors and disease 
transmission. Going forward, conducting controlled experiments in outdoor enclosures where 
host densities are held constant will allow for more robust evaluations of the effects of 
interspecific competition and seasonality on stress physiology, immunity and intraspecific 
contact rates in our system and other directly-transmitted disease systems.  
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Table 4. 1 List of hypotheses for how heterospecific competitors and seasonality will associate 
with stress physiology, immunity, and contact rates of deermice, with corresponding predictions 
and empirical support for each measured variable. Seasonality hypotheses received support if 
there was consistency across both years.  
Hypothesis  Prediction Support? 
Heterospecific competitors  
(voles, and to a lesser extent,  
shrews) 
↑ stress  ↑ Baseline FCMs † No 
  ↓ Stress response FCMs † Yes (shrews) 
  ↑ N/L ratio ‡ No 
  ↓ BCS § Yes (both) 
↓ immunity ↓ WBC counts ¶ No 
˗ or Δ contacts  ˗ or Δ scar numbers Yes Δ (both) 




↑ Baseline FCMs † 
↓ Stress response FCMs † 
↑ N/L ratio ‡ 





↓ immunity ↓ WBC counts ¶ Yes (summer) 
↑ contacts ↑ scar numbers Yes (summer) 
† Fecal corticosterone metabolites 
‡ Neutrophil/lymphocyte ratio 
§ Body condition score 






Figure 4. 1 Small mammal densities for each grid (A-D) across study period (October 2016 to 
August 2018). Deermouse and vole densities were estimated using Minimum Number Alive 




Figure 4. 2 Regression tree for stress response fecal corticosterone metabolites (FCMs) of 
deermice. Each terminal node provides a sample size with a boxplot for that subgroup. Density is 




Figure 4. 3 Regression tree for ln neutrophil to lymphocyte (N/L) ratio of deermice. Each 
terminal node provides a sample size with a boxplot for that subgroup. Grids A and B were 
trapped October’16 – July’18. Grids C and D were trapped October’17 – August’18. Juveniles 
and subadults were grouped into “Non-Adult”. F1, S1, Su1, F2, S2, and Su2 represent 
Fall/Winter‘16, Spring‘17, Summer’17, Fall/Winter’17, Spring’18, and Summer’18, 




Figure 4. 4 Regression tree for body condition score (BCS) of deermice. Each terminal node 
provides a sample size with a boxplot for that subgroup. “ReproStatus” stands for reproductive 
status. Juveniles and subadults were grouped together into “Non-Adult”. F1, S1, Su1, F2, S2, and 
Su2 represent Fall/Winter‘16, Spring‘17, Summer’17, Fall/Winter’17, Spring’18, and 







Figure 4. 5 Regression tree of white blood cell (WBC) counts of deermice. Each terminal node 
provides a sample size with a boxplot for that subgroup. Grids A and B were trapped October’16 
– July’18. Grids C and D were trapped October’17 – August’18. F1, S1, Su1, F2, S2, and Su2 
represent Fall/Winter‘16, Spring‘17, Summer’17, Fall/Winter’17, Spring’18, and Summer’18, 




Figure 4. 6 Regression tree for scar numbers of deermice. Each terminal node provides a sample 
size with a boxplot for that subgroup. Density is per hectare. “ReproStatus” stands for 
reproductive status. S1, F2, Su1, S2, and Su2 represent Spring‘17, Fall/Winter’17, Summer’17, 












Grid descriptions: Most common grasses at grid A were intermediate wheatgrass (Agropyron 
intermedium) and smooth brome (Bromus sp.), at grid B, slender wheatgrass (Elymus 
trachycaulus) and timothy grass (Phleum pratense), at grid C, smooth brome and timothy grass, 
and at grid D, intermediate wheatgrass and wild oat (Avena fatua). Grid B had the most forbs 
including mustards (Brassica spp.), thistles (Cirsium spp.) and whitetop (Lepidium draba), and 




































CHAPTER 5 INTERSPECIFIC COMPETITION CAN LEAD TO NON-MONOTONIC 
DISEASE OUTCOMES: A THEORETICAL INVESTIGATION WITH A DIRECTLY-
TRANSMITTED ZOONOSIS 
ABSTRACT  
The “dilution effect” and “amplification effect” hypotheses predict negative and positive 
monotonic relationships, respectively, between biodiversity and disease. However, non-
monotonic patterns have also received support, and community composition, such as 
heterospecific competitors, has been argued to be more important than biodiversity per se. 
Because underlying mechanisms of dilution and amplification have been studied less with 
directly-transmitted disease systems, here, we theoretically investigated how a heterospecific 
competitor could affect disease outcomes via disparate mechanisms in such a system. To mimic 
a natural system, we used realistic parameters for Sin Nombre virus, hosted by the North 
American deermouse (Peromyscus maniculatus), with the vole (Microtus spp.) serving as the 
competitor. Because such competitors could affect host density, behavior, and physiological 
stress, we used a mathematical model with density-dependent transmission, to explore how 
competitor density could influence disease prevalence through these transmission mechanisms 
(either singly or combined). Our results indicated that, although dilution was more commonly 
predicted than amplification, a non-monotonic relationship (increase then decrease), was the 
most commonly predicted outcome in the parameter space we examined. Taken together, our 
findings broadly highlight that heterospecific competitors could, via competing mechanisms, 
generate non-monotonic disease outcomes within the same system, which could indeed be 




Globally, species diversity has been declining, while emerging infectious diseases of 
humans and animals have been increasing (Daszak et al. 2000; Jones et al. 2008; Cardinale et al. 
2012). To explain this pattern, the “dilution effect” hypothesis proposes that as species diversity 
decreases, infectious disease risk increases because diversity “dilutes” disease (Keesing et al. 
2006). Although most empirical evidence suggests that the dilution effect is prevalent in nature 
(Civitello et al. 2015), many have argued against its generality across disease systems (Randolph 
& Dobson 2012; Wood et al. 2014). This is partially because of evidence supporting the 
“amplification effect” hypothesis, which proposes that as diversity decreases, disease risk also 
decreases (Keesing et al. 2006; Salkeld et al. 2013). However, community composition (e.g., 
heterospecific competitors), and not diversity per se, has been argued to be more relevant 
(Randolph & Dobson 2012; Johnson et al. 2015), a concept termed the “identity effect” (Huang 
et al. 2016).  
Regardless of whether species diversity or community composition is considered, there 
has been more attention given towards the shapes of the patterns present (i.e. dilution versus 
amplification), instead of the underlying mechanisms that dictate those patterns. Such critical 
mechanistic work has been performed predominantly with vector-borne diseases, such as Lyme 
disease (e.g., Ostfeld & Keesing 2000), and environmentally-transmitted diseases, such as 
chytridiomycosis (e.g., Venesky et al. 2014), with directly-transmitted diseases receiving 
comparatively less attention (Luis et al. 2018). If we can broadly document how key mechanistic 
drivers interact together to govern the net disease outcome, we can better understand the shapes 
of the outcomes observed in natural systems (Wood et al. 2016; Halliday & Rohr 2019; Rohr et 
al. 2020). Consequently, we will be better equipped to predict the shapes of disease outcomes 
across host-parasite systems and environmental contexts.  
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Based on epidemiological theory, diversity can affect prevalence of a directly-transmitted 
disease, with one primary reservoir host, via three key mechanisms: intraspecific contact rates, 
probability of transmission given contact (hereafter probability of transmission), and infectious 
period, which is determined by infected host mortality and recovery (Keesing et al. 2006). The 
transmission rate of a disease, commonly referred to as β, is the product of contact rates, βc 
(behavioral component), and probability of transmission, βp (physiological component), for a 
given host density (Hawley et al. 2011). With density-dependent transmission, intraspecific 
contact rates are expected to increase directly with host density, N, that is the true contact rate is 
equal to βc N, where βc is a constant (Begon et al. 2002). Therefore, when diversity affects host 
density, it will indirectly affect intraspecific contact rates. For diversity to directly affect the true 
contact rate, it needs to do so via βc, independent of host density, N (e.g. via causing hosts to 
behaviorally aggregate in refugia). Because βc and βp are difficult to estimate from empirical data 
(Hawley et al. 2011), they are often collapsed to the single parameter, β. However, this has 
received valid criticism because crucial information about transmission could be otherwise lost 
(McCallum et al. 2017; White et al. 2018). In order to clearly understand the effects of diversity 
on disease outcomes, we need to examine how diversity can affect each of the key mechanisms 
independently and ascertain the potential for interactions (synergistic or antagonistic) among 
mechanisms that could impact the net outcome.  
Rodent-hantavirus systems have been employed as models of directly-transmitted disease 
systems for studying relationships between diversity (or community composition) and disease. 
Hantaviruses are primarily transmitted between hosts via bites and are closely associated with 
one primary reservoir species that once infected, never recovers (Jonsson et al. 2010). An 
example of such a system is the Sin Nombre virus (SNV) and its primary host, the North 
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American deermouse (Peromyscus maniculatus, hereafter deermouse), which has received 
considerable attention in the dilution effect literature (e.g., Mills 2006; Clay et al. 2009a; Rubio 
et al. 2017; Luis et al. 2018). The deermouse is the primary reservoir for SNV in North America 
(Childs et al. 1994), and this system exhibits direct (Warner et al. 2019) and density-dependent 
transmission (Luis et al. 2015). Although dilution is the effect primarily found in this system 
(e.g., Calisher et al. 2002; Mills 2006; Clay et al. 2009a; Dizney & Ruedas 2009; Lehmer et al. 
2012), neutral relationships between diversity and disease have also been identified (Orrock et al. 
2010; Milholland et al. 2017; Vadell et al. 2020). However, the mechanisms responsible for these 
patterns have been studied comparatively less (Clay et al 2009b; Dizney & Dearing 2016; Rubio 
et al. 2017). Most importantly, Luis et al. (2018) found that dilution and amplification can occur 
concurrently within the same system and are driven by different mechanisms. In particular, the 
authors found that an overall dilution effect in the Southwest United States was driven by 
deermouse density, despite a concurrent “component amplification effect”– a positive 
relationship between diversity and SNV transmission rate, β, at a given deermouse density. 
Therefore, the deermouse-SNV system presents an ideal opportunity to examine how key 
mechanisms could work in tandem to influence the net disease outcome; a concept that applies 
across host-parasite systems. 
Studies testing the “dilution effect” hypothesis in the deermouse-SNV system have 
largely focused on small mammal diversity instead of broader diversity measures. Consequently, 
the patterns observed between disease and diversity (or community composition) in this system, 
most likely stem from interspecific competition exerted on deermice, by one or more small 
mammal competitors. Therefore, the deermouse-SNV system allows us to tease apart how and 
why a heterospecific competitor can alter the spread of a directly-transmitted disease. In 
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particular, the deermouse-SNV system in grasslands of western Montana, USA, provides a 
suitable framework. There are two main reasons why this is the case. Firstly, deermice primarily 
compete with voles (Microtus spp.) in simple small mammal communities (Eleftheriou et al. 
2021). Unlike deermice, voles are considered dead-end hosts for SNV (Mills 2006). Secondly, 
voles are dominant competitors of deermice and could regulate their density (e.g., Redfield et al. 
1977), alter their intraspecific contact rates (i.e. interference competition; Grant 1971), and 
suppress their immunity via a rise in physiological stress, thereby potentially increasing 
probability of transmission (Dickens & Romero 2013; Fredebaugh-Siller et al. 2013, Eleftheriou 
et al. 2021). Therefore, voles could influence SNV prevalence via multiple mechanisms, and the 
simpler community in western Montana allows us to disentangle their relative importance on 
disease outcomes.  
Our study objective was to broadly examine, in a theoretical yet realistic framework, how 
community composition, represented here by a heterospecific competitor, could affect disease 
prevalence, via multiple key mechanisms, within a directly-transmitted disease system that 
exhibits density-dependent transmission. To accomplish this, we modified a deterministic model 
previously validated for the deermouse-SNV system (Luis et al. 2015) to include a heterospecific 
competitor. Because we wanted to evaluate an array of potential, yet realistic, disease outcomes, 
we varied the strength of vole-induced effects on deermouse density (i.e. regulatory interspecific 
competition), contact rates (βc), and probability of transmission (βp), as best informed by 
published data. Importantly, although our study focused on the deermouse-SNV system within a 
simple small mammal community, we emphasize that our modeling approach could be modified, 







Susceptible-infected-recovered (SIR) models are compartmentalized models developed to 
track disease dynamics within a host population. The compartments are connected through 
parameters that allow one host to leave one compartment and enter another (Anderson & May 
1979). For example, a host can leave the susceptible compartment and enter the infected 
compartment, through transmission from an infected individual. Our model incorporates 
background birth and death rates of all deermouse classes irrespective of age or sex. This 
approach has been successful in predicting SNV dynamics in deermouse populations (Luis et al. 
2018). Our model also incorporates logistic growth where there is density-dependence in 
background birth and death rates, and assumes density-dependent transmission (Luis et al. 2015). 
Because deermice never recover from infection, there is no recovered compartment (Mills et al. 
1999). Our model also incorporates disease-induced mortality (Luis et al. 2012). The following 
model is based on the model from Luis et al. (2018), with the addition of vole density (V), a 
competition coefficient (α), β split into its behavioral and physiological components, and 
removal of immigration of infected individuals:  
 
                                   (1a) 
         (1b) 
 
 
where N is the total deermouse density (S+I) , S is the susceptible deermouse density, I is the 
infected deermouse density, K is the fixed carrying capacity for deermice, b is the maximum 
birth rate (in absence of density-dependence), d is the minimum death rate, c is the proportion of 
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density dependence attributed to density dependence in birth rates, r is the intrinsic growth of the 
population (b-d) , µ is the disease-induced mortality rate, α is the Lotka-Volterra competition 
coefficient that measures the effect of vole density on deermouse density in the absence of 
disease, V is vole density, βc is the contact rate, and βp is the probability of transmission (Table 
1).  
 In order to theoretically examine a comprehensive range of the regulatory pressure 
deermice could experience from voles, we initially selected three α values that spanned from 
weak competition (α = 0.8) to competitive exclusion (α = 2). Later, we explored the full range 
from 0 to 2, in a broader analysis. 
 
DECONSTRUCTING TRANSMISSION RATE 
Given that no previous studies have estimated βc and βp separately, we explored a range 
of plausible values for β informed by Luis et al. (2018). These authors estimated a range of 
values from various Montana field sites (Table S5.1). We used this range to first calculate a 
mean transmission rate. Given that βp can only take values between 0 and 1, we assumed an 
arbitrary value of 0.5 in the absence of effects from competitor density ( ); we later performed 
an elasticity analysis to test how this parameter affects the outcome. A value for a contact rate in 
the absence of effects from competitors ( ) was calculated by dividing the mean transmission 
rate by 0.5. This approach allowed our simulations to generate β estimates within the reported 
range (Luis et al. 2018) and thus, keep our findings realistic (Table S5.1). 
Because of ambiguity as to how deermouse contact rates change with diversity or 
competitor density (Clay et al. 2009b; Rubio et al. 2017; Luis et al. 2018; Eleftheriou et al. 
2021), we either allowed density-independent contact rates to stay constant ( , increase, 
or decrease with competitor density using the equation below: 
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 ,          (2)  
where  is the effect of vole density, V (Table 2). At the highest simulated V (V = 20), βc reaches 
its lowest value, 0, when  (Figure 5.1A, Table 5.1). However, this changes when 
 , where βc reaches its highest value, 0.04257778, at the highest V. We decided on this 
mathematical expression for ψ because we wanted to incorporate scenarios where the competitor 
could completely block intraspecific contact rates when at their highest density (V = 20). 
Previous evidence suggests that vole density can impact measures of physiological stress 
in deermice (Fredebaugh-Siller et al. 2013, Eleftheriou et al. 2021). A sustained increase in 
physiological stress could suppress host immunity, which could increase probability of 
transmission as a result, here modeled by:   
 ,         (3)   
where γ is the effect from vole density, V. The probability of transmission, βp, increases with vole 
density but as a probability it is constrained between 0 and 1 with the logit function. In the 
absence of vole-induced effects, probability of transmission remains constant ( . We 
elected to model the relationship between βp and V using three different γ values (0.03, 0.15, 
0.30), which allowed us to explore how a range in the rates of increase in physiological stress 
could affect the final outcome (Figure 5.1B, Table 5.1).  
ESTIMATING CRITICAL HOST DENSITY 
 
Because SNV has density-dependent transmission, we can calculate a critical host density (Nc), 
below which SNV cannot persist. We can examine how voles could influence Nc, and thus, SNV 
prevalence indirectly, by:  
 ,         (4)          
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RUNNING MODEL SIMULATIONS FOR ALL SCENARIOS 
 
We used R (version 4.0.3, R Core Team 2018) within RStudio (RStudio Team 2015) to run all 
scenario simulations where we initially tested three α values (0.8, 1.2, 2), three γ values (0.03, 
0.15, 0.30) and three ψ values (0, ±0.001064445) across a range of V (V = 0-20) (Figure 5.1). To 
solve differential equations, we used the R package “deSolve” (Soetaert et al. 2010). We 
introduced one infected deermouse in a population of 29 susceptible deermice, while keeping 
environmental carrying capacity, K, constant at 30 deermice. In the end, we ran each of the 
scenarios for 100 time steps (months), which was enough to reach equilibrium in all simulations. 
SNV prevalence was estimated as density of infected deermice divided by the total density of 
deermice at equilibrium. We ensured that our simulation results remained within a realistic 
context by confirming that the β values we generated were within or near the range previously 
reported (Table S5.1).  
To demonstrate in a larger parameter space what outcomes would be possible, we ran 
another set of simulations with a wider range of α, γ and ψ values that generated 5859 possible 
combinations. Additionally, to better generalize our findings to other disease systems, we ran a 
broader sensitivity analysis where we varied system-specific parameters or variables that were 
typically kept fixed in our model simulations, to understand their effect on disease outcomes 
(fixed parameters and variables in Table 5.1). To do this, we varied fixed parameter or variable 
values by ±10% or 30% and generated outcomes for the simulation scenario where ψ was kept at 
zero (center square in Figure 5.3). 
RESULTS 
 
COMPETITOR AFFECTS EACH MECHANISM INDIVIDUALLY 
Firstly, we examined the impact of competitor density on disease outcomes via each individual 
mechanism of transmission (host density, density-independent contact rates and probability of 
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transmission) separately, by varying α, ψ, and γ , one at a time, and evaluating how each 
parameter, in isolation, influenced the relationship between competitor density and disease 
prevalence. If disease prevalence (at equilibrium) declined as competitor density increased, we 
considered this a “dilution effect”, i.e. the competitor “diluted” disease. Alternatively, if disease 
prevalence increased with competitor density, we considered this an “amplification effect”.  
We found that as the strength of interspecific competition (α) increased, the competitor 
more strongly regulated host density, leading to a steeper decline in density. We observed 
extinction of hosts (competitive exclusion) at α = 2 at intermediate competitor densities, for our 
simulated scenario of K = 30. This reduction in host density led to a decrease in disease 
prevalence (due to density-dependent transmission) and disease extinction when host density (N) 
declined below the critical host density (Nc) (Figure S5.1). Thus, as the strength of interspecific 
competition (α) increased, disease extinction happened at lower competitor densities (V) and a 
dilution effect occurred.  
As the strength of stress-induced immunosuppression (γ) increased, competitor density 
(V) had a greater effect on the probability of transmission (βp), leading to higher disease 
prevalence at lower competitor densities and, thus, an amplification effect (Figure S5.2).  
When we allowed the competitor to influence contact rates (βc) between hosts, we found 
that a positive ψ (competitor increases βc) led to an amplification effect, whereas a negative ψ 
(competitor decreases βc) generated a dilution effect (Figure S5.3).  
Taken together, our findings demonstrate that dilution or amplification can occur in this 





COMPETITOR AFFECTS VARIOUS MECHANISMS SIMULTANEOUSLY 
Next, we explored how the combination of competitor regulation (α) and stress-induced 
immunosuppression (γ) could affect disease outcomes by simultaneously varying α and γ, while 
holding ψ at zero (no direct effect of competitor on density-independent contact rates). With 
stronger interspecific competition (α = 2), the negative effect of competitor density (V) on host 
density (N), and thus, density-dependent transmission, outweighed the positive effect of V on the 
probability of transmission (βp), leading to dilution. The only exception was when V had a 
stronger effect on βp (γ = 0.3) where a non-monotonic relationship occurred (figure 2, figure A4). 
A dilution effect was also predicted when the effect of competitor density (V) on βp was weak (γ 
= 0.03). However, the combination of weaker competition (α < 2) and intermediate to strong 
effect of V on βp (γ > 0.03), led to a non-monotonic relationship between competitor density (V) 
and disease prevalence, such that prevalence increased at lower competitor densities (V), was 
highest at low to intermediate V, and then decreased at higher V (Figure 5.2).  
 Next, we added the potential effect of the competitor on intraspecific contact rates (βc) by 
varying the effect of competitor density (V) on βc (while varying α and γ). When competitor 
density, V, increased intraspecific contact rates, βc (positive ψ), a wider parameter space 
generally led to a non-monotonic relationship between competitor density and disease prevalence 
(Figure S5.4). The only exception was when V had a stronger regulatory effect (α = 2) on host 
density but a weaker effect on probability of transmission, βp (γ = 0.03), resulting in dilution 
(Figure S5.5). However, when competitor density, V , decreased βc (negative ψ), a wider 
parameter space most often led to a dilution effect, whereas a non-monotonic relationship was 




Lastly, we explored a broader parameter space to characterize which parameter 
combinations led to dilution (decrease), amplification (increase), or a non-monotonic (increase 
followed by decrease) relationship between competitor density, V, and disease prevalence. Only 
when ψ < -5e-04 (i.e. V decreases βc), a greater portion of parameter space predicted a dilution 
effect (light purple, Figure 5.3). Indeed, this effect gradually comprised a narrower parameter 
space as the effect of V on contact rates (βc), ψ, reached its maximum value (parameter space 
from 61.9% to 3.8%). A non-monotonic relationship was predicted most commonly when α was 
lower (i.e. weaker regulatory strength) and γ was higher (i.e., greater stress-induced 
immunosuppression). This relationship gradually comprised a wider parameter space (increased 
from 38.1% to 70.5%) as the effect of V on contact rates (βc), ψ, reached its maximum value 
(dark green, Figure 5.3). Importantly, a non-monotonic relationship was predicted even when 
there was no regulatory effect on host density (α = 0), suggestive that the sole interactions 
between components of the transmission rate (βc and βp) can still manifest in non-monotonic 
outcomes. Additionally, an amplification effect emerged (dark purple, Figure 5.3), although 
across a narrower parameter space (ranged from 9.2% to 25.7%), when ψ ≥ 0 (i.e. V has no effect 
or increases βc) and interspecific competition was weaker (α < 0.5). Taken together, dilution 
became less prominent across the parameter space we examined as the effect of competitor 
density on contact rates, ψ, switched from negative to positive values, whereas a non-monotonic 
relationship became the most commonly predicted outcome. Overall, an amplification effect was 
the least predicted outcome, which only appeared under restricted conditions given realistic 
parameter values for this system.   
In order to extend our findings beyond the deermouse-SNV system, we conducted a 
broader elasticity analysis where we varied parameters or variables previously assumed to be 
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fixed (Table 5.1) in a standardized manner (Tables S5.2-S5.5). These findings did not indicate 
any significant deviations from our conclusions suggesting that our simulation findings are 
robust to the fixed parameter and variable values we used in this study. Indeed, the greatest 
change that we observed was relatively small, ~ 12% reduction in dilution for 30% decrease in 
the intercept for contact rates, βc0 (Tables S5.2, S5.4).  
 
DISCUSSION 
Using a directly-transmitted disease system, we theoretically examined possible effects of 
interspecific competition on three mechanisms of transmission (i.e. host density, density-
independent contact rates, and probability of transmission). We show that monotonic 
(amplification or dilution) and, most importantly, non-monotonic relationships between 
competitor density and disease prevalence can occur under a range of realistic parameter values. 
Non-monotonic relationships between diversity and disease have been previously considered, 
typically across a land-type gradient (e.g. urban-forest). However, here we show that non-
monotonic relationships could also occur due to antagonistic interactions of key mechanisms 
within the same study system. 
The most intriguing finding of our study was a non-monotonic relationship that was the 
most commonly predicted outcome in the parameter space we examined (~60%, Figure 5.3). 
This relationship was characterized by an increase in disease prevalence at lower competitor 
densities (V), a peak at intermediate V, and a decline at higher V (Figure 5.2). Regardless of an 
effect on contact rates (βc), this outcome was most evident when the competitor (1) weakly 
regulated host density (N), and (2) had a greater effect on the probability of transmission (βp) via 
stress-induced immunosuppression.  
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Such non-monotonic relationships have been previously considered between diversity 
and disease because when there are no host or vector species present (e.g., a parking lot or urban 
center), no to little disease risk would be expected, and therefore amplification would need to 
occur prior to any dilution (Wood et al. 2016; Kirkpatrick et al. 2017). This concept has been 
exemplified with the Lyme disease system, which requires the presence of multiple host and 
vector species for sustained transmission (Wood & Lafferty 2013). For instance, in urban areas 
with zero diversity, there will be no hosts (e.g. mice or deer) or vectors (i.e. ticks), and thus, 
Lyme disease cannot persist. However, diversity is expected to increase when moving across 
different land-types, such as from urban to rural as suggested for the Lyme disease system. As 
competent hosts and vectors become more likely to be present along this gradient, an 
amplification effect can manifest. However, in areas with higher levels of diversity, represented 
by forests in the Lyme disease system, more non-competent hosts are also likely to be present, 
which can lead to a dilution effect. 
However, our study suggests that non-monotonic relationships between diversity and 
disease could occur for another reason, the result of competing mechanisms within the same 
study system. This novel result could explain why non-monotonic relationships between 
diversity and disease have been reported in various systems (Halliday & Rohr 2019). 
Importantly, our findings could explain why some studies have found no diversity-disease 
patterns in the deermouse-SNV system (Orrock et al. 2010, Milholland et al. 2017; Vadell et al. 
2020). To demonstrate this concept, we added stochasticity to simulation findings where non-
monotonic patterns were most notable (e.g., when α = 0.8 and ψ = 0), where we show that fitted 
linear regressions can only find neutral patterns as they are inherently unable to identify non-
monotonic relationships (figure A7). Given that linear relationships are typically the patterns 
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searched for in field studies, non-monotonic outcomes could be easily mistaken for the absence 
of a pattern in the presence of stochasticity. Although findings similar to our own were also 
shown by a recent theoretical study (Lee & Mohd 2020), the transmission rate, (β), was not 
deconstructed into its two components. Therefore, our study further extends their findings, 
introduces guidelines for when a non-monotonic relationship could occur in the presence of 
interspecific competition, and provides theoretical support for why empirical studies may find no 
diversity-disease patterns in natural systems. 
Dilution was the second most commonly predicted outcome (~29%) in the parameter 
space we examined, with amplification rarely predicted (~11%). Conversely, dilution was the 
sole outcome found by theoretical studies that examined the regulatory role of a non-competent 
competitor on host density in a directly-transmitted disease system with density-dependent 
transmission (Peixoto & Abramson 2006; O’Regan et al. 2015). Importantly, dilution is often 
reported in empirical studies with the deermouse-SNV system (e.g., Mills 2006; Clay et al. 
2009a; Dizney & Ruedas 2009). In contrast, amplification has received limited support and only 
as a weak effect (Luis et al. 2018). Indeed, our findings support that amplification could be less 
common in nature given that it occurred in a narrower parameter space, where the relationship 
between contact rates (βc) and competitor density (V ) was primarily neutral or positive, and 
when the regulatory effect (α) on host density (N) was weak or absent. Therefore, our findings 
provide theoretical support for a more common dilution, than amplification effect in nature, at 
least within the parameter space used for this disease system.  
Our findings of the great potential for competitor density to lead to a non-monotonic 
relationship with disease prevalence is contingent upon the parameter space examined. We 
informed our model with realistic parameter values for the deermouse-SNV system with vole 
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competitors, and the results of our broader elasticity analysis suggest that our conclusions are 
largely robust to the fixed parameter/variable values that we used to inform the model. 
Therefore, our conclusions likely apply to other directly-transmitted disease systems that 
experience interspecific competition. Despite uncertainties in parameter values, we are confident 
that a non-monotonic outcome between competitor density and disease prevalence could arise 
from a wide range of parameter space, especially since it was by far, the most commonly 
predicted relationship in the parameter space we examined. 
Although we acknowledge that a two-species framework implies that we did not examine 
diversity per se, as would be expected for placing our findings within a dilution effect context, 
there are three primary reasons as to why our approach and findings are still relevant to the 
“dilution effect” hypothesis. Firstly, community composition (e.g., heterospecific competitors) 
has been suggested to be more relevant (Randolph & Dobson 2012). Secondly, a simple two-
species system has been exploited by others when asking similar questions (Peixoto & Abramson 
2006; O’Regan et al. 2015). Lastly, competitive interactions are most likely the primary 
ecological process by which small mammal diversity (typically used as the diversity index in 
deermouse-SNV studies) can actually impact hantavirus prevalence.  
It is important to note that our findings are based on equilibrium conditions, which are 
not always found in natural disease systems, such as the deermouse-SNV system (Luis et al. 
2015). Although rodent densities and their environmental carrying capacities will vary across 
time and space, we elected to keep these fixed to allow for a more tangible examination of our 
research objective. Additional layers of complexity where rodent densities and their carrying 
capacities can vary across time and space will be useful, but these were beyond the scope of this 
study. Furthermore, we did not examine infectious period as a mechanism to keep our modeling 
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framework more tractable and because this mechanism has received scant empirical attention. 
Therefore, future studies can investigate how non-equilibrium conditions could affect our 
findings and incorporate competitor-induced effects on infectious period in more complex 
modeling frameworks.   
A passionate debate has been ongoing (Randolph & Dobson 2012; Ostfeld 2013; Ostfeld 
& Keesing 2013; Wood & Lafferty 2013) since the “dilution effect” hypothesis was first 
formally proposed (Ostfeld & Keesing 2000). Although we did not focus on species diversity per 
se, it is more likely that community composition (e.g., competitor species) is more relevant in 
how disease outcomes manifest (Randolph & Dobson 2012; Johnson et al. 2015; Kilpatrick et al. 
2017). Therefore, focusing on the density of relevant species, such as heterospecific competitors, 
may provide more explanatory or predictive power than broad measures of diversity (e.g. species 
richness or evenness). By placing our study within the dilution effect framework, we propose 
that monotonic and non-monotonic relationships can theoretically occur within the same system 
depending on the interaction strengths of mechanisms that work in tandem. Therefore, to 
advance the field forward, we need to consider the co-occurring effects of relevant mechanisms 
under realistic ecological scenarios. We predict that our findings and approach can extend 
diversity-disease theory, stimulate novel empirical studies, and inform disease management in 
applied settings.  
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Table 5. 1 Variables and parameters used in the models with descriptions and estimates. 
Parameter Value Description 
K 30 Carrying capacity of deermice (per hectare) (Eleftheriou et al. 2021) 
V 0-20 Vole competitor density (per hectare) (Eleftheriou et al. 2021) 
α 0.8,1.2, 2 Competition coefficient  
c 0.6142470 Density-dependent effect on birth rates (Luis et al. 2015) 
b 0.3154089 Maximum birth rate of deermice (Luis et al. 2015) 
d 3.655774e-05 Minimum death rate of deermice (Luis et al. 2015) 






Density-independent contact rate in the absence of voles  
 
Probability of transmission in the absence of voles (Luis et al. 2018) 
βp0 0.5 Probability of transmission in the absence of voles  
ψ 0,±0.001064445 Effect on intraspecific contact rate from vole density  











Figure 5. 1 Relationships of density-independent contact rate (βc) (A) and probability of 
transmission (βp) (B) with competitor density (V). A. The effect of V on βc, (ψ), was set to either 
zero (—) to denote constant βc, or 0.001064445  (—) and - 0.001064445 (—), to denote 
increasing or decreasing βc with V, respectively. The intercept was set to 0.02128889. B. The 
effect of V on βp, (γ), was set to either 0.03  (—), 0.15 (—), or 0.30 (—), to develop 









Figure 5. 2 Relationships between Sin Nombre virus (SNV) prevalence and vole competitor 
density. The effect of the competitor on host density (α) and probability of transmission (γ) via 
stress-induced immunosuppression, were varied as shown, while assuming constant density-







Figure 5. 3 Parameter space of 5859 combinations of α, γ and ψ values corresponding to their 
respective outcome for a fixed competitor density, V, (0-20). Dark purple signifies an 
amplification effect or a sole increase in disease prevalence, light purple, a dilution effect or a 
sole decline in prevalence, light green, no change in prevalence (i.e. represents baseline when all 
parameters are set to zero), and dark green, a non-monotonic relationship between prevalence 
and competitor density. The percentage values indicate the proportion of parameter space 












SUPPLEMENTARY INFORMATION  
 
Figure S5. 1 Total deermouse (host) density, N, (- - -), and critical host density, Nc, (—) 
relationships with vole competitor density, V, (top row), and respective outcome between Sin 
Nombre virus (SNV) prevalence (bottom row) and V. The effect of competitors on contact rates, 
(ψ), and probability of transmission, (γ), were kept at zero. The effect of competitors on host 




Figure S5. 2 Total deermouse (host) density, N, (- - -), and critical host density, Nc, (—) 
relationships with vole competitor density, V, (top row), and respective outcome between Sin 
Nombre virus (SNV) prevalence (bottom row) and V. The effect of competitors on host density 
(α), and contact rates (ψ) were kept at zero. The effect of competitors on the probability of 




Figure S5. 3 Total deermouse (host) density, N, (- - -), and critical host density, Nc, (—) 
relationships with vole competitor density, V, (top row), and respective outcome between Sin 
Nombre virus (SNV)  prevalence (bottom row) and V. The effect of competitors on host density 
(α) and on the probability of transmission (γ) were kept at zero. The effect of competitors on 




Figure S5. 4 Total deermouse (host) density, N, (- - -), and critical host density, Nc, (—) 
relationships with vole competitor density, V, to complement figure 2 in the main text. The effect 
of competitors on host density (α) and on the probability of transmission (γ) were varied as 




Figure S5. 5 Total deermouse (host) density, N, (- - -), and critical host density, Nc, (—) 
relationships with vole competitor density, V, (top row), and respective outcome between Sin 
Nombre virus (SNV) prevalence (bottom row) and V. The effect of competitors on host density 
(α) and probability of transmission (γ) were varied as shown, while the effect of competitors on 





Figure S5. 6 Total deermouse (host) density, N, (- - -), and critical host density, Nc, (—) 
relationships with vole competitor density, V, (top row), and respective outcome between Sin 
Nombre virus (SNV) prevalence (bottom row) and V. The effect of competitors on host density 
(α) and probability of transmission (γ) were varied as shown, while the effect of competitors on 





Figure S5. 7Relationships between Sin Nombre virus (SNV) prevalence and vole competitor 
density as modeled with linear regression  (—) when competitors have a weak effect on host 
density (α = 0.8) and no effect on contact rate (ψ = 0), a scenario shown in Figure 5.2 of the main 
text. When we add a degree of stochasticity to the simulated data, an obvious dilution effect can 
only be seen when a monotonic relationship is predicted (γ = 0.03). Otherwise, no pattern is 














Table S5. 1 Model-estimated β values generated from all possible simulations compared to 
published β values from Montana, USA. 
Parameter Mean  Standard deviation Range 
β (this study) 0.01592162 0.00772337 0 – 0.0424725 


























Table S5. 2 Results of broad elasticity analyses where the effect of competitor density on 
intraspecific contact rates, βc, (ψ), was kept at zero (scenario in center of Figure 5.3 in main text). 
Parameters and variables were changed ± 30% to visualize the percentage change in disease 
outcomes compared to their fixed values (Table 5.1 in main text). For each figure inset, the 
horizontal axis, represents γ, the degree of stress-induced immunosuppression (range; 0-0.3) 
while the vertical axis represents α, the strength of regulatory competition (range; 0-2), both of 
which are effects exerted on hosts by competitor density. Dark purple signifies an amplification 
effect, light purple, a dilution effect, light green, no change in prevalence (i.e. represents baseline 


















Table S5. 3 Results of elasticity analyses where the effect of competitor density on contact rates, 
βc, (ψ), was kept at zero (scenario in center of Figure 5.3). Parameters and variables were 
changed to document the percentage change in non-monotonic outcomes compared to their fixed 
values. Red signifies increase, blue decrease, and gray no change. 
 
% ∆ βp0 βc0 c b d μ 
+30 0 -1.70 -2.20 0.48 0 0.24 
+10 0 -0.96 -0.96 0.24 0 0 
-10 0 0.71 0.48 -1.21 0 0 






Table S5. 4 Results of elasticity analyses where the effect of competitor density on contact rates, 
βc, (ψ), was kept at zero (scenario in center of Figure 5.3). Parameters and variables were 
changed to document the percentage change in dilution outcomes compared to their fixed values. 
Red signifies increase, blue decrease, and gray no change. 
 
% ∆ βp0 βc0 c b d μ 
+30 0 4.47 5.52 -3.64 0 -0.59 
+10 0 2.29 2.29 -1.18 0 0 
-10 0 -2.40 -1.18 2.84 0 0 













Table S5. 5 Results of elasticity analyses where the effect of competitor density on contact rates, 
βc, (ψ), was kept at zero (scenario in center of Figure 5.3). Parameters and variables were 
changed to document the percentage change in amplification outcomes compared to their fixed 
values. Red signifies increase, blue decrease, and gray no change. 
 
% ∆ βp0 βc0 c b d μ 
+30 0 -1.69 -1.69 6.25 0 0 
+10 0 0 0 1.64 0 0 
-10 0 1.64 0 0 0 0 
-30 0 7.69 0 -3.45 0 3.23 
 
 
 
 
 
 
 
 
 
